Mouse Genome Informatics Coronavirus Information Center

The Global COVID-19 Pandemic

Coronavirus disease (COVID-19) is an infectious disease caused by a novel member of the coronavirus family of viruses. Since Covid-19 was declared a global pandemic on March 11, 2020, millions of cases of have been documented in 192 countries and regions worldwide (Johns Hopkins University; World Health Organization)

About this Site: Coronavirus Research using the Laboratory Mouse

The laboratory mouse is an important preclinical model for studying coronavirus biology and treatment approaches. The information on this site summarizes information about mouse strains and genes relevant to the study of coronavirus infection and pathology. This information has been expertly curated from pre-prints and peer-reviewed publications dating back to the 1980s by biocuration scientists from the Mouse Genome Informatics (MGI) knowledgebase hosted at The Jackson Laboratory.

See all curated publications that report on mouse models and genes related to coronaviruses in MGI.

Mouse Strains Used in Coronavirus Research

Mouse strains used in coronavirus research with associated mouse phenotype categories and human disease terms and references citing the use of the mouse strains in coronavirus research. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.

Mouse strain names are linked to strain detail pages at MGI. Human disease terms are linked to the Disease ontology resource at MGI. References are linked to the reference detail pages at MGI.

1-strain	2-mgi	3-attrs	4-geno-mgi	5-allele	6-allele-mgi	7-type	8-subtypes	9-do-term	10-do-id	11-mp-term	12-mp-id	13-cite	14-jnum	15-tags	Strain	Genotype Details	Human Disease and Mouse Phenotype Categories	References \| Keywords
129-Ifngr1^tm1Agt/J	MGI:2165098	mutant strain\|targeted mutation	MGI:6403197	Ifngr1^tm1Agt	MGI:1857286	Targeted	Null/knockout			immune system	MP:0005387	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849	J:286237	Pathology\|SARS-CoV-MA_virus	129-Ifngr1^tm1Agt/J mutant strain\|targeted mutation	MGI:6403197	immune system	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus
129S1/SvImJ	MGI:3037980	inbred strain	MGI:3582226							behavior/neurological immune system	MP:0005386 MP:0005387	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	129S1/SvImJ inbred strain	MGI:3582226	behavior/neurological immune system	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(129S1/SvImJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865672	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(129S1/SvImJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
129S2/SvPasCrl	MGI:3587894	inbred strain										Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Ying B, bioRxiv 2022 Feb;(): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302	J:328107 J:321873 J:336008	SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta	129S2/SvPasCrl inbred strain			Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta
129S6/SvEv-Stat1^tm1Rds/Tac	MGI:3771555	mutant strain\|targeted mutation	MGI:3771372	Stat1^tm1Rds	MGI:1861949	Targeted	Null/knockout	breast cancer severe acute respiratory syndrome	DOID:1612 DOID:2945	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton mortality/aging neoplasm	MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0005370 MP:0005369 MP:0003631 MP:0005388 MP:0005390 MP:0010768 MP:0002006	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849	J:286237	Pathology\|SARS-CoV-MA_virus	129S6/SvEv-Stat1^tm1Rds/Tac mutant strain\|targeted mutation	MGI:3771372	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton mortality/aging neoplasm breast cancer severe acute respiratory syndrome	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus
129S6/SvEvTac	MGI:3044417	inbred strain										Roberts A, Virus Res 2008 Apr;133(1):20-32 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303	J:286331 J:286332	Infection\|SARS-CoV_virus\|Vaccine SARS-CoV_virus	129S6/SvEvTac inbred strain			Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus
129X1/SvJ	MGI:3044210	inbred strain										Okumura A, J Virol 1996 Jun;70(6):4146-9	J:52540	Mouse_Hepatitis_virus	129X1/SvJ inbred strain			Okumura A, J Virol 1996 Jun;70(6):4146-9 Mouse_Hepatitis_virus
A/J	MGI:2159747	inbred strain	MGI:3807714					Coronavirus infectious disease	DOID:0080599	hearing/vestibular/ear hematopoietic system immune system nervous system	MP:0005377 MP:0005397 MP:0005387 MP:0003631	Dangi T, bioRxiv 2021 Jun;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Lee M, bioRxiv 2020 Dec;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Tian J, bioRxiv 2020;(): Tian J, bioRxiv 2021 Feb;(): Wang GZ, bioRxiv 2020;(): Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:308670 J:288204 J:268979 J:276026 J:161935 J:299101 J:27269 J:295388 J:302152 J:296066 J:36900 J:276183	SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus Mouse_Hepatitis_virus\|SARS-CoV-2_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Treatment Comorbidity\|SARS-CoV-2_virus	A/J inbred strain	MGI:3807714	Coronavirus infectious disease hearing/vestibular/ear hematopoietic system immune system nervous system	Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Lee M, bioRxiv 2020 Dec;(): Mouse_Hepatitis_virus\|SARS-CoV-2_virus Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Mouse_Hepatitis_virus Tian J, bioRxiv 2020;(): Mouse_Hepatitis_virus\|Treatment Tian J, bioRxiv 2021 Feb;(): Mouse_Hepatitis_virus\|Treatment Wang GZ, bioRxiv 2020;(): Comorbidity\|SARS-CoV-2_virus Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
A/JCr	MGI:6156905	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	A/JCr inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
(A/J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865666	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(A/J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
Arc:ARC(S)	MGI:5306408	outbred stock										Eldi P, bioRxiv 2021 Sep;():	J:310113	SARS-CoV-2_virus\|Vaccine	Arc:ARC(S) outbred stock			Eldi P, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine
B10.BR-H2^k2 H2-T18^a/SgSnJ	MGI:2386242	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	B10.BR-H2^k2 H2-T18^a/SgSnJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
B10.D2-Hc⁰ H2^d H2-T18^c/oSnJ	MGI:2160070	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	B10.D2-Hc⁰ H2^d H2-T18^c/oSnJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
B6.129(Cg)-Foxp3^{tm4(YFP/icre)Ayr}/J	MGI:5306407	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129(Cg)-Foxp3^{tm4(YFP/icre)Ayr}/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129(Cg)-Wwtr1^tm1.2Hmc/J	MGI:6285617	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129(Cg)-Wwtr1^tm1.2Hmc/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129-Ido1^tm1Alm/J	MGI:3603213	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129-Ido1^tm1Alm/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129P2-Ace2^tm1Pngr/J	MGI:5912242	congenic\|mutant strain\|targeted mutation	MGI:5912243 MGI:6402915	Ace2^tm1Pngr	MGI:2661723	Targeted	Null/knockout			cardiovascular system immune system	MP:0005385 MP:0005387	Kuba K, Nat Med 2005 Aug;11(8):875-9	J:286299	Infection\|SARS-CoV_virus	B6.129P2-Ace2^tm1Pngr/J congenic\|mutant strain\|targeted mutation	MGI:5912243 MGI:6402915	cardiovascular system immune system	Kuba K, Nat Med 2005 Aug;11(8):875-9 Infection\|SARS-CoV_virus
B6.129P2(C)-Cd19^tm1(cre)Cgn/J	MGI:3710504	congenic\|mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6.129P2(C)-Cd19^tm1(cre)Cgn/J congenic\|mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.129P2-Ccr2^tm1Mae	MGI:3841132	congenic\|targeted mutation	MGI:3841005	Ccr2^tm1Mae	MGI:2158345	Targeted	Null/knockout	age related macular degeneration Coronavirus infectious disease	DOID:10871 DOID:0080599	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye	MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Ccr2^tm1Mae congenic\|targeted mutation	MGI:3841005	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2-Ccr5^tm1Kuz	MGI:4418878	congenic\|mutant strain\|targeted mutation	MGI:4418655	Ccr5^tm1Kuz	MGI:1861911	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Ccr5^tm1Kuz congenic\|mutant strain\|targeted mutation	MGI:4418655	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2(Cg)-Yap1^tm1.1Dupa/J	MGI:6259136	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129P2(Cg)-Yap1^tm1.1Dupa/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129P2-Cxcr3^tm1Dgen/J	MGI:3604638	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129P2-Cxcr3^tm1Dgen/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129P2-Cxcr6^tm1Litt/J	MGI:3696273	congenic\|mutant strain\|targeted mutation										Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:327836	SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	B6.129P2-Cxcr6^tm1Litt/J congenic\|mutant strain\|targeted mutation			Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
B6.129P2-Igh^em1Rcas/J	MGI:6725129	congenic\|endonuclease-mediated mutation\|mutant strain										Xu J, Nature 2021 Jun 7;():	J:307753	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma	B6.129P2-Igh^em1Rcas/J congenic\|endonuclease-mediated mutation\|mutant strain			Xu J, Nature 2021 Jun 7;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma
B6.129P2-Lyz2^tm1(cre)Ifo/J	MGI:2680712	congenic\|mutant strain\|targeted mutation										Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology\|SARS-CoV-2_virus	B6.129P2-Lyz2^tm1(cre)Ifo/J congenic\|mutant strain\|targeted mutation			Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus
B6.129P2-Myd88^tm1Aki	MGI:3697090	congenic\|mutant strain\|targeted mutation	MGI:3577712	Myd88^tm1Aki	MGI:2385681	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005381 MP:0005377 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Myd88^tm1Aki congenic\|mutant strain\|targeted mutation	MGI:3577712	cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2-Nos2^tm1Lau/J	MGI:2163101	congenic\|mutant strain\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	B6.129P2-Nos2^tm1Lau/J congenic\|mutant strain\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
B6.129P2-Rbpj^tm1Hon/HonRbrc	MGI:3761296	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129P2-Rbpj^tm1Hon/HonRbrc congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129P2-Sirpa^tm1Nog/Rbrc	MGI:3763171	congenic\|mutant strain\|targeted mutation										Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	B6.129P2-Sirpa^tm1Nog/Rbrc congenic\|mutant strain\|targeted mutation			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
B6.129P2(SJL)-Myd88^tm1.1Defr	MGI:6272303	congenic\|mutant strain\|targeted mutation	MGI:6272304	Myd88^tm1.1Defr	MGI:4421295	Targeted	Null/knockout			behavior/neurological hematopoietic system immune system nervous system mortality/aging	MP:0005386 MP:0005397 MP:0005387 MP:0003631 MP:0010768	Butchi N, J Virol 2015 Sep 15;89(18):9299-312	J:224849	Infection\|Mouse_Hepatitis_virus\|Pathology	B6.129P2(SJL)-Myd88^tm1.1Defr congenic\|mutant strain\|targeted mutation	MGI:6272304	behavior/neurological hematopoietic system immune system nervous system mortality/aging	Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Infection\|Mouse_Hepatitis_virus\|Pathology
B6.129S2-Cd8a^tm1Mak/J	MGI:2163961	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129S2-Cd8a^tm1Mak/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129S2(Cg)-Ace2^{tm1(ACE2)Dwnt}/J	MGI:6469882	congenic\|mutant strain\|targeted mutation										Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Zhou B, Nature 2021 Apr;592(7852):122-127	J:338414 J:331773 J:305777	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus	B6.129S2(Cg)-Ace2^{tm1(ACE2)Dwnt}/J congenic\|mutant strain\|targeted mutation			Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus
B6.129S2-Ciita^tm1Ccum/J	MGI:2164648	congenic\|mutant strain\|targeted mutation										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.129S2-Ciita^tm1Ccum/J congenic\|mutant strain\|targeted mutation			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.129S2-Ifnar1^tm1Agt/Mmjax	MGI:4836218	congenic\|mutant strain\|targeted mutation										Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:319459 J:345954	Infection\|SARS-CoV-2_virus Infection\|MERS-CoV-MA_virus	B6.129S2-Ifnar1^tm1Agt/Mmjax congenic\|mutant strain\|targeted mutation			Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S2-Ighm^tm1Cgn/J	MGI:2163831	congenic\|mutant strain\|targeted mutation										Israelow B, bioRxiv 2021 May;():	J:308733	Infection\|SARS-CoV-2_virus	B6.129S2-Ighm^tm1Cgn/J congenic\|mutant strain\|targeted mutation			Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus
B6.129S2-Plat^tm1Mlg/J	MGI:2162973	congenic\|mutant strain\|targeted mutation	MGI:6433845	Plat^tm1Mlg	MGI:1857288	Targeted	Null/knockout			immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	B6.129S2-Plat^tm1Mlg/J congenic\|mutant strain\|targeted mutation	MGI:6433845	immune system mortality/aging	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
B6.129S2-Serpine1^tm1Mlg/J	MGI:2162090	congenic\|mutant strain\|targeted mutation	MGI:3690223	Serpine1^tm1Mlg	MGI:1857287	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	B6.129S2-Serpine1^tm1Mlg/J congenic\|mutant strain\|targeted mutation	MGI:3690223	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging Coronavirus infectious disease	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
B6.129S2-Tcra^tm1Mom/J	MGI:2162335	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:343550	Infection\|SARS-CoV-2_virus\|Treatment	B6.129S2-Tcra^tm1Mom/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
B6.129S2-Tnfrsf1b^tm1Mwm/J	MGI:2164652	congenic\|mutant strain\|targeted mutation	MGI:3580520	Tnfrsf1b^tm1Mwm	MGI:1857262	Targeted	Null/knockout			cellular hematopoietic system immune system	MP:0005384 MP:0005397 MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S2-Tnfrsf1b^tm1Mwm/J congenic\|mutant strain\|targeted mutation	MGI:3580520	cellular hematopoietic system immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6;129S4-C3^tm1Crr/J	MGI:2165043	mutant stock\|targeted mutation	MGI:3799624	C3^tm1Crr	MGI:1861799	Targeted	Null/knockout			homeostasis/metabolism immune system nervous system vision/eye	MP:0005376 MP:0005387 MP:0003631 MP:0005391	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	B6;129S4-C3^tm1Crr/J mutant stock\|targeted mutation	MGI:3799624	homeostasis/metabolism immune system nervous system vision/eye	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
B6.129S4-Ccr1^tm1Gao	MGI:3614571	congenic\|mutant strain\|targeted mutation	MGI:3614443	Ccr1^tm1Gao	MGI:1931850	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129S4-Ccr1^tm1Gao congenic\|mutant strain\|targeted mutation	MGI:3614443	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129S4-Ccr2^tm1Ifc/J	MGI:3038272	congenic\|mutant strain\|targeted mutation	MGI:3580323	Ccr2^tm1Ifc	MGI:2158213	Targeted	Null/knockout			cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0002006 MP:0010768	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92	J:106738	Mouse_Hepatitis_virus\|Pathology	B6.129S4-Ccr2^tm1Ifc/J congenic\|mutant strain\|targeted mutation	MGI:3580323	cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus\|Pathology
B6(129S4)-Ly6e^{tm1c(EUCOMM)Hmgu}/JwschJ	MGI:6507729	mutant strain\|targeted mutation										Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	B6(129S4)-Ly6e^{tm1c(EUCOMM)Hmgu}/JwschJ mutant strain\|targeted mutation			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
B6;129S5-Ace2^tm1Lex/Mmucd	MGI:5498467	mutant strain\|targeted mutation										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6;129S5-Ace2^tm1Lex/Mmucd mutant strain\|targeted mutation			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6;129S6-Apaf1^tm1Her/J	MGI:2178674	mutant stock\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	B6;129S6-Apaf1^tm1Her/J mutant stock\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S6-Cd4^tm1Knw/J	MGI:2162768	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129S6-Cd4^tm1Knw/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129S6-Ch25h^tm1Rus/J	MGI:4947858	congenic\|mutant strain\|targeted mutation										Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	B6.129S6-Ch25h^tm1Rus/J congenic\|mutant strain\|targeted mutation			Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
B6.129S6-Nlrp3^tm1Bhk/J	MGI:5465029	congenic\|mutant strain\|targeted mutation										Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:331762 J:323769	Mouse_Hepatitis_virus Gene\|Pathology	B6.129S6-Nlrp3^tm1Bhk/J congenic\|mutant strain\|targeted mutation			Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6;129S6-Ppp1r14c^tm1Uhl/J	MGI:4839337	mutant stock\|targeted mutation	MGI:6433773	Ppp1r14c^tm1Uhl	MGI:4450989	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6;129S6-Ppp1r14c^tm1Uhl/J mutant stock\|targeted mutation	MGI:6433773	immune system Coronavirus infectious disease	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129S6-Ptges2^tm1Bhk/J	MGI:3833371	congenic\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S6-Ptges2^tm1Bhk/J congenic\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129S6-Shh^{tm2(cre/ERT2)Cjt}/J	MGI:3612945	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6.129S6-Shh^{tm2(cre/ERT2)Cjt}/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.129S7-Cd47^tm1Fpl/J	MGI:2165071	congenic\|mutant strain\|targeted mutation										Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	B6.129S7-Cd47^tm1Fpl/J congenic\|mutant strain\|targeted mutation			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
B6.129S7-Ifngr1^tm1Agt/J	MGI:2164369	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:343550	Infection\|SARS-CoV-2_virus\|Treatment	B6.129S7-Ifngr1^tm1Agt/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
B6.129S7-Ifng^tm1Ts	MGI:3713227	congenic\|mutant strain\|targeted mutation	MGI:4365971	Ifng^tm1Ts	MGI:1857184	Targeted	Null/knockout			endocrine/exocrine glands hematopoietic system immune system mortality/aging neoplasm	MP:0005379 MP:0005397 MP:0005387 MP:0010768 MP:0002006	Parra B, J Immunol 1999 Feb 1;162(3):1641-7	J:112048	Infection\|Mouse_Hepatitis_virus	B6.129S7-Ifng^tm1Ts congenic\|mutant strain\|targeted mutation	MGI:4365971	endocrine/exocrine glands hematopoietic system immune system mortality/aging neoplasm	Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Infection\|Mouse_Hepatitis_virus
B6.129S7-Ifng^tm1Ts/J	MGI:2162391	congenic\|mutant strain\|targeted mutation										Sun J, Cell 2020 Jun 10;():	J:291881	Infection\|Pathology\|SARS-CoV-2_virus\|Treatment	B6.129S7-Ifng^tm1Ts/J congenic\|mutant strain\|targeted mutation			Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S7-Rag1^tm1Mom/J	MGI:2163461	congenic\|mutant strain\|targeted mutation										Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Hassan AO, Cell 2020 Jun 10;(): Israelow B, bioRxiv 2021 May;(): Mao T, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:88552 J:92752 J:290258 J:308733 J:308656 J:345954	Mouse_Hepatitis_virus Infection\|SARS-CoV_virus Infection\|SARS-CoV-2_virus\|Treatment Infection\|SARS-CoV-2_virus Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|MERS-CoV-MA_virus	B6.129S7-Rag1^tm1Mom/J congenic\|mutant strain\|targeted mutation			Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Mouse_Hepatitis_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(C)-Batf3^tm1Kmm/J	MGI:5287249	congenic\|mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6.129S(C)-Batf3^tm1Kmm/J congenic\|mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(Cg)-Stat1^tm1Dlv/J	MGI:4452071	congenic\|mutant strain\|targeted mutation										Hassan AO, Cell 2020 Jun 10;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Sun J, Cell 2020 Jun 10;():	J:290258 J:345954 J:291881	Infection\|SARS-CoV-2_virus\|Treatment Infection\|MERS-CoV-MA_virus Infection\|Pathology\|SARS-CoV-2_virus\|Treatment	B6.129S(Cg)-Stat1^tm1Dlv/J congenic\|mutant strain\|targeted mutation			Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S-Csf2^tm1Mlg/J	MGI:5613598	congenic\|mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6.129S-Csf2^tm1Mlg/J congenic\|mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(FVB)-Bcl6^tm1.1Dent/J	MGI:5518537	congenic\|mutant strain\|targeted mutation										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.129S(FVB)-Bcl6^tm1.1Dent/J congenic\|mutant strain\|targeted mutation			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.129S-Notch2^tm3Grid/J	MGI:4441345	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129S-Notch2^tm3Grid/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129S-Sftpc^{tm1(cre/ERT2)Blh}/J	MGI:5661884	congenic\|mutant strain\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.129S-Sftpc^{tm1(cre/ERT2)Blh}/J congenic\|mutant strain\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.129S-Tnfrsf1b^tm1Imx Tnfrsf1a^tm1Imx/J	MGI:2164568	congenic\|mutant strain\|targeted mutation	MGI:6433775	Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx	MGI:1857468 MGI:1860087	Targeted	Null/knockout			immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S-Tnfrsf1b^tm1Imx Tnfrsf1a^tm1Imx/J congenic\|mutant strain\|targeted mutation	MGI:6433775	immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129-Tlr2^tm1Kir/J	MGI:2673281	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129-Tlr2^tm1Kir/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129-Tnfrsf1a^tm1Mak/J	MGI:2164398	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129-Tnfrsf1a^tm1Mak/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129X1-Fgl2^tm1Pam	MGI:3583761	congenic\|mutant strain\|targeted mutation	MGI:3583697	Fgl2^tm1Pam	MGI:3582343	Targeted	Null/knockout\|Reporter			cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging	MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005367 MP:0010768	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66	J:99453	Mouse_Hepatitis_virus	B6.129X1-Fgl2^tm1Pam congenic\|mutant strain\|targeted mutation	MGI:3583697	cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 Mouse_Hepatitis_virus
B6.129X1-Ifng^tm1Yiw	MGI:6430477	congenic\|mutant strain\|targeted mutation	MGI:6430478	Ifng^tm1Yiw	MGI:3036127	Targeted	Null/knockout			behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005386 MP:0005381 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0010768	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77	J:50405 J:91691	Mouse_Hepatitis_virus\|Pathology Infection\|Mouse_Hepatitis_virus\|Pathology	B6.129X1-Ifng^tm1Yiw congenic\|mutant strain\|targeted mutation	MGI:6430478	behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Mouse_Hepatitis_virus\|Pathology Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection\|Mouse_Hepatitis_virus\|Pathology
B6.129X1-Notch1^tm2Rko/GridJ	MGI:3777345	congenic\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129X1-Notch1^tm2Rko/GridJ congenic\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.B10ScN-Tlr4^lps-del/JthJ	MGI:3777588	congenic\|spontaneous mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.B10ScN-Tlr4^lps-del/JthJ congenic\|spontaneous mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/Mmjax	MGI:2174641	mutant strain\|transgenic										Chen J, Transl Psychiatry 2023 Dec 16;13(1):396	J:348471	Gene\|Infection\|SARS-CoV-2_virus	B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/Mmjax mutant strain\|transgenic			Chen J, Transl Psychiatry 2023 Dec 16;13(1):396 Gene\|Infection\|SARS-CoV-2_virus
B6.Cg-Aicda^tm1Hon/HonRbrc	MGI:3690652	congenic\|mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6.Cg-Aicda^tm1Hon/HonRbrc congenic\|mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.Cg-B2m^tm1Unc Cd4^tm1Litt H2-Ab1^b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orl	MGI:5494679	congenic\|mutant strain\|targeted mutation\|transgenic										Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	B6.Cg-B2m^tm1Unc Cd4^tm1Litt H2-Ab1^b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orl congenic\|mutant strain\|targeted mutation\|transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
B6(Cg)-C1qa^{tm1d(EUCOMM)Wtsi}/TennJ	MGI:6151470	mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6(Cg)-C1qa^{tm1d(EUCOMM)Wtsi}/TennJ mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.Cg-Ces1c^tm1.1Loc/J	MGI:4939039	congenic\|mutant strain\|targeted mutation										Martinez DR, bioRxiv 2021 Jan;(): Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Zhu C, Nat Commun 2022 Aug 3;13(1):4503	J:302135 J:298752 J:335969	SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment	B6.Cg-Ces1c^tm1.1Loc/J congenic\|mutant strain\|targeted mutation			Martinez DR, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment
B6(Cg)-Ctnnb1^tm1Knw/J	MGI:5796192	mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6(Cg)-Ctnnb1^tm1Knw/J mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.Cg-Edil3^{Tg(Sox2-cre)1Amc}/J	MGI:3800753	congenic\|transgenic										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Edil3^{Tg(Sox2-cre)1Amc}/J congenic\|transgenic			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Fcgrt^tm1Dcr Prkdc^scid Tg(FCGRT)32Dcr/DcrJ	MGI:5424138	congenic\|mutant strain\|spontaneous mutation\|targeted mutation\|transgenic										Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	B6.Cg-Fcgrt^tm1Dcr Prkdc^scid Tg(FCGRT)32Dcr/DcrJ congenic\|mutant strain\|spontaneous mutation\|targeted mutation\|transgenic			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
B6.Cg-Foxn1^nu/J	MGI:2163103	congenic\|mutant strain\|spontaneous mutation										Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:33974	Mouse_Hepatitis_virus	B6.Cg-Foxn1^nu/J congenic\|mutant strain\|spontaneous mutation			Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
B6.Cg-Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/J	MGI:3813512	congenic\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/J congenic\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/J	MGI:3584524	congenic\|mutant strain\|targeted mutation										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6.Cg-Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/J congenic\|mutant strain\|targeted mutation			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6(Cg)-Ifnar1^tm1.1Ees/J	MGI:5692164	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6(Cg)-Ifnar1^tm1.1Ees/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6(Cg)-Ifnar1^tm1.2Ees/J	MGI:5692173	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Mao T, bioRxiv 2021 Jun;(): Sun J, Cell 2020 Jun 10;(): Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Yang J, Nature 2020 Jul 29;():	J:343550 J:308656 J:291881 J:338414 J:292665	Infection\|SARS-CoV-2_virus\|Treatment Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron SARS-CoV-2_virus\|Vaccine	B6(Cg)-Ifnar1^tm1.2Ees/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6(Cg)-Igh^{tm3.1(VRC01)Nemz}/J	MGI:5795592	mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6(Cg)-Igh^{tm3.1(VRC01)Nemz}/J mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}	MGI:6449003	congenic\|mutant strain\|targeted mutation\|transgenic	MGI:6449004	Commd10^{Tg(Vav1-icre)A2Kio} Ly6e^{tm1c(EUCOMM)Hmgu}	MGI:2449949 MGI:6448980	Transgenic Targeted	Null/knockout\|Recombinase Conditional ready			hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0010768	Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio} congenic\|mutant strain\|targeted mutation\|transgenic	MGI:6449004	hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging	Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
B6.Cg-Mx1^tm1.1Agsa/J	MGI:6280430	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6.Cg-Mx1^tm1.1Agsa/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.Cg-Prkdc^scid/SzJ	MGI:2163184	congenic\|mutant strain\|spontaneous mutation										Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:33974	Mouse_Hepatitis_virus	B6.Cg-Prkdc^scid/SzJ congenic\|mutant strain\|spontaneous mutation			Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
B6.Cg-Shh^{tm1(EGFP/cre)Cjt}/J	MGI:3619470	congenic\|mutant strain\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Shh^{tm1(EGFP/cre)Cjt}/J congenic\|mutant strain\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn}/J	MGI:2164673	congenic\|mutant strain\|transgenic										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn}/J congenic\|mutant strain\|transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6(Cg)-Sting1^tm1.2Camb/J	MGI:5639268	congenic\|mutant strain\|targeted mutation										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6(Cg)-Sting1^tm1.2Camb/J congenic\|mutant strain\|targeted mutation			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6.Cg-Terc^tm1Rdp/J	MGI:2174164	congenic\|mutant strain\|targeted mutation										Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity\|Gene Gene	B6.Cg-Terc^tm1Rdp/J congenic\|mutant strain\|targeted mutation			Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
B6.Cg-Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/Mmjax	MGI:3811801	congenic\|transgenic										Hohsfield LA, Glia 2022 May;70(5):875-891	J:324342	Mouse_Hepatitis_virus	B6.Cg-Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/Mmjax congenic\|transgenic			Hohsfield LA, Glia 2022 May;70(5):875-891 Mouse_Hepatitis_virus
B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ	MGI:5566534	congenic\|mutant strain\|transgenic										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ congenic\|mutant strain\|transgenic			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.Cg-Tg(DPP4)2Nnag	MGI:6403117	congenic\|mutant strain\|transgenic	MGI:6403118	Tg(DPP4)2Nnag	MGI:6403115	Transgenic	Humanized sequence\|Inserted expressed sequence	Middle East respiratory syndrome	DOID:0080642	homeostasis/metabolism immune system respiratory system	MP:0005376 MP:0005387 MP:0005388	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6):	J:286321	Infection\|MERS-CoV_virus	B6.Cg-Tg(DPP4)2Nnag congenic\|mutant strain\|transgenic	MGI:6403118	homeostasis/metabolism immune system respiratory system Middle East respiratory syndrome	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Infection\|MERS-CoV_virus
B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc	MGI:6415225	congenic\|mutant strain\|transgenic										Jia H, Nat Commun 2020 Oct 14;11(1):5165 Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53	J:296535 J:287092	SARS-CoV-2_virus Infection	B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc congenic\|mutant strain\|transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Infection
B6.Cg-Tg(Itgax-cre)1-1Reiz/J	MGI:3763375	congenic\|mutant strain\|transgenic										Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Anand G, bioRxiv 2020 Dec;():	J:333092 J:298270	Gene\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus	B6.Cg-Tg(Itgax-cre)1-1Reiz/J congenic\|mutant strain\|transgenic			Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Gene\|VOC_B.1.351_Beta Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.Cg-Tg(K18-ACE2)2Prlmn/J	MGI:6389236	congenic\|mutant strain\|transgenic	MGI:6455041	Tg(K18-ACE2)2Prlmn	MGI:6389235	Transgenic	Humanized sequence\|Inserted expressed sequence	COVID-19	DOID:0080600	behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Afkhami S, bioRxiv 2021 Jul;(): Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 Amruta N, bioRxiv 2021 May;(): Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 Awosanya OD, Bone 2022 Jan;154():116227 Barreiro A, bioRxiv 2021 Dec;(): Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Belouzard S, bioRxiv 2021 Jun;(): Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 Biswas R, bioRxiv 2021 Feb;(): Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 Carossino M, bioRxiv 2021 Jan;(): Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 Ceon E, bioRxiv 2022 Jan;(): Chan CEZ, PLoS One 2021;16(6):e0253487 Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 Chaparian RR, bioRxiv 2021 Apr;(): Chen EC, Cell Rep 2021 Aug 24;36(8):109604 Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Chen JS, bioRxiv 2020 Sep 25;(): Chen JS, bioRxiv 2021 Jun;(): Chen JS, J Virol 2021 Jan 13;(): Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Clark JJ, bioRxiv 2020;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): Dangi T, J Clin Invest 2022 Dec 1;132(23): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Do MH, PLoS One 2023;18(9):e0291537 Drayman N, Science 2021 Aug 20;373(6557):931-936 Dubuc I, Front Immunol 2022;13():893792 Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 Duty JA, Med 2022 Oct 14;3(10):705-721.e11 Elia U, bioRxiv 2021 Mar;(): El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 Fumagalli V, bioRxiv 2021 Aug;(): Garcia-Arriaza J, J Virol 2021 Jan 7;(): Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Gawish R, Elife 2022 Jan 13;11():e74623 Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 Golden JW, JCI Insight 2020 Aug 25;(): Goncalves R, iScience 2023 Feb 17;26(2):105972 Grandi A, bioRxiv 2021 Jul;(): Greer CD, bioRxiv 2021 Aug;(): Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Hastie KM, Cell Rep 2023 May 30;42(5):112421 Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 Hilligan KL, bioRxiv 2021 Aug;(): Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Ho JSY , bioRxiv 2020 Dec;(): Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 Hong J, bioRxiv 2021 Oct;(): Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 Humphries F, Sci Immunol 2021 May 18;6(59): Hunt AC, bioRxiv 2021 Jul;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Jaki L, Nat Commun 2023 Apr 10;14(1):1999 Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 Jeong GU, bioRxiv 2022;(): Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Joag V, J Immunol 2021 Mar 1;206(5):931-935 Johnson BA, Nature 2021 Mar;591(7849):293-299 Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Kim JW, Front Immunol 2023;14():1271508 Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 Ku MW, bioRxiv 2021 Feb;(): Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Lee KS, bioRxiv 2022;(): Lee S, Nature 2021 Nov;599(7884):283-289 Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Li K, mBio 2021 Aug 31;12(4):e0097021 Lin X, bioRxiv 2021 Dec;(): Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Li W, Cell Rep 2022 Jan 11;38(2):110210 Lu A, Int J Mol Sci 2024 Feb 8;25(4): Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 Manangeeswaran M, Front Immunol 2022;13():919815 Mao T, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2022;(): Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 Mao T, Science 2022 Nov 25;378(6622):eabo2523 Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Marx S, bioRxiv 2021 Aug;(): Matchett WE, J Immunol 2021 Jun 30;(): McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Mejia OR, bioRxiv 2021 Nov;(): Nagai M, Nat Commun 2023 Jun 30;14(1):3863 Natekar JP, bioRxiv 2022 Apr;(): Noy-Porat T, bioRxiv 2021 Feb;(): Noy-Porat T, iScience 2021 May 21;24(5):102479 Oktay E, Commun Biol 2023 Mar 23;6(1):308 Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Olivarria GM, bioRxiv 2021 Nov;(): Oliveira VLS, Front Immunol 2024;15():1378591 Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 Perez P, Front Immunol 2022;13():995235 Perez P, Front Immunol 2023;14():1264323 Puhl AC, bioRxiv 2021;(): Puhl AC, bioRxiv 2021 Dec;(): Qin Z, Theranostics 2021;11(16):8076-8091 Radvak P, bioRxiv 2021 Jun;(): Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Robertson SJ, bioRxiv 2021 Sep;(): Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Salzer R, bioRxiv 2021 May;(): Scaglione A, bioRxiv 2021 Jun;(): Scaglione A, Front Immunol 2021;12():719077 Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 Seehusen F, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Silvas J, bioRxiv 2021 Mar;(): Sims JJ, bioRxiv 2021 Apr;(): Slamanig S, EBioMedicine 2024 Jun 6;105():105185 Smeyne RJ, bioRxiv 2022 Feb;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Song E, J Exp Med 2021 Mar 1;218(3): Soni DK, bioRxiv 2020 Dec;(): Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 Subramaniam S, bioRxiv 2021 Aug;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Su P, Mol Brain 2022 Aug 9;15(1):71 Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 Syenina A, PLoS Biol 2022 May;20(5):e3001643 Tada T, Cell Rep 2020 Dec 22;33(12):108528 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Tarres-Frexas F, bioRxiv 2021 Aug;(): Tatham L, bioRxiv 2022;(): Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Ullah i, bioRxiv 2021 Mar;(): Ullah I, iScience 2024 Mar 15;27(3):109049 van Bergen J, JCI Insight 2023 Nov 8;8(21): VanBlargan LA, Immunity 2021 Aug 19;(): Van Dyke MC, bioRxiv 2021 May;(): van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Venzon M, bioRxiv 2021 Jul;(): Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Weiss S, Int J Mol Sci 2023 May 5;24(9): Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 White KM, Science 2021 Feb 26;371(6532):926-931 Winkler ES, bioRxiv 2020 Dec;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Winkler ES, Nat Immunol 2020 Aug 24;(): Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Ying B, bioRxiv 2022 Feb;(): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 Zhang L, bioRxiv 2022 Mar;(): Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Zheng J, bioRxiv 2020 Aug 10;(): Zheng J, Nature 2021 Jan;589(7843):603-607 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Zhu C, Nat Commun 2022 Aug 3;13(1):4503 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47	J:335907 J:308640 J:335897 J:335960 J:308724 J:349496 J:319441 J:315723 J:310110 J:308621 J:335929 J:302158 J:348328 J:300428 J:294058 J:321756 J:309634 J:335919 J:308713 J:335928 J:331767 J:298866 J:308655 J:300110 J:321761 J:325089 J:296067 J:309512 J:308652 J:348326 J:331763 J:349970 J:336017 J:335961 J:335898 J:349963 J:303462 J:335924 J:343775 J:343658 J:308584 J:300041 J:335902 J:318828 J:339694 J:294084 J:348327 J:308639 J:308745 J:284000 J:335892 J:309629 J:319459 J:338412 J:335945 J:309197 J:343550 J:298250 J:308894 J:313447 J:335952 J:333769 J:308637 J:308733 J:331753 J:348329 J:335899 J:321757 J:348325 J:296535 J:303898 J:307033 J:335935 J:313337 J:296686 J:349972 J:319440 J:319447 J:349971 J:335933 J:302144 J:319366 J:321763 J:334872 J:343773 J:313329 J:315744 J:299104 J:303465 J:335931 J:349976 J:335930 J:331765 J:308656 J:321770 J:349979 J:335986 J:349938 J:308571 J:348320 J:283648 J:349980 J:315717 J:337953 J:324941 J:302148 J:308896 J:335997 J:300960 J:315722 J:348063 J:335939 J:335976 J:343770 J:311915 J:316769 J:319458 J:308643 J:296397 J:340506 J:335918 J:310124 J:338561 J:303472 J:308749 J:308666 J:335910 J:335943 J:304647 J:308716 J:302912 J:304613 J:350298 J:322638 J:312952 J:302314 J:299096 J:343790 J:309192 J:322631 J:331766 J:335949 J:335947 J:313439 J:338414 J:308579 J:321766 J:309630 J:303209 J:348954 J:349973 J:336018 J:308721 J:349977 J:308642 J:336189 J:328107 J:336005 J:323957 J:303457 J:299082 J:331773 J:294083 J:317125 J:335996 J:339218 J:321873 J:336008 J:324936 J:330045 J:305460 J:293212 J:303220 J:308903 J:335969 J:283999	Comorbidity\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|Variant SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus Gene\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|Variant SARS-CoV-2_virus\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Comorbidity\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus Vaccine Pathology\|SARS-CoV-2-MA_virus Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Infection\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|Treatment Infection\|Pathology\|SARS-CoV-2_virus\|Variant SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma Pathology\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Gene\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|SARS-CoV_virus Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|Vaccine PASC\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron Pathology\|SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma	B6.Cg-Tg(K18-ACE2)2Prlmn/J congenic\|mutant strain\|transgenic	MGI:6455041	behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging COVID-19	Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Comorbidity\|SARS-CoV-2_virus Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Pathology\|SARS-CoV-2_virus Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 SARS-CoV-2_virus\|Vaccine\|Variant Amruta N, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Awosanya OD, Bone 2022 Jan;154():116227 Pathology\|SARS-CoV-2_virus Barreiro A, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): SARS-CoV-2_virus Belouzard S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 SARS-CoV-2_virus\|Treatment Biswas R, bioRxiv 2021 Feb;(): Gene\|SARS-CoV-2_virus Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 SARS-CoV-2_virus\|Treatment\|Variant Carossino M, bioRxiv 2021 Jan;(): Pathology\|SARS-CoV-2_virus Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 SARS-CoV-2_virus\|Vaccine Ceon E, bioRxiv 2022 Jan;(): SARS-CoV-2_virus\|Treatment Chan CEZ, PLoS One 2021;16(6):e0253487 SARS-CoV-2_virus\|Treatment Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 SARS-CoV-2_virus\|Treatment Chaparian RR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Chen EC, Cell Rep 2021 Aug 24;36(8):109604 SARS-CoV-2_virus\|Treatment Chen IP, Cell Rep 2022 Jul 19;40(3):111088 SARS-CoV-2_virus Chen JS, bioRxiv 2020 Sep 25;(): SARS-CoV-2_virus\|Treatment Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta Chen JS, J Virol 2021 Jan 13;(): SARS-CoV-2_virus\|Treatment Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Clark JJ, bioRxiv 2020;(): Comorbidity\|Pathology\|SARS-CoV-2_virus Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Pathology\|SARS-CoV-2_virus Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Dangi T, J Clin Invest 2022 Dec 1;132(23): SARS-CoV-2_virus\|Treatment de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Do MH, PLoS One 2023;18(9):e0291537 SARS-CoV-2_virus\|Treatment Drayman N, Science 2021 Aug 20;373(6557):931-936 SARS-CoV-2_virus\|Treatment Dubuc I, Front Immunol 2022;13():893792 Pathology\|SARS-CoV-2_virus Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 SARS-CoV-2_virus Duty JA, Med 2022 Oct 14;3(10):705-721.e11 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Elia U, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 SARS-CoV-2_virus\|Treatment Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 SARS-CoV-2_virus\|Treatment Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus Fumagalli V, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus Garcia-Arriaza J, J Virol 2021 Jan 7;(): Vaccine Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Gene\|SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 SARS-CoV-2_virus Golden JW, JCI Insight 2020 Aug 25;(): Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias Goncalves R, iScience 2023 Feb 17;26(2):105972 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta Grandi A, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Greer CD, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 SARS-CoV-2_virus\|Vaccine Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus\|Vaccine Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Hastie KM, Cell Rep 2023 May 30;42(5):112421 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 SARS-CoV-2_virus Hilligan KL, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment Ho JSY , bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 SARS-CoV-2_virus\|Treatment Hong J, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Humphries F, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus\|Treatment Hunt AC, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Infection\|SARS-CoV-2_virus Jaki L, Nat Commun 2023 Apr 10;14(1):1999 SARS-CoV-2_virus\|Treatment Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Jeong GU, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Pathology\|SARS-CoV-2_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Joag V, J Immunol 2021 Mar 1;206(5):931-935 SARS-CoV-2_virus\|Vaccine Johnson BA, Nature 2021 Mar;591(7849):293-299 SARS-CoV-2_virus Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 SARS-CoV-2_virus\|Vaccine Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Pathology\|SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 Infection\|Pathology\|SARS-CoV-2_virus\|Variant Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Pathology\|SARS-CoV-2_virus Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 SARS-CoV-2_virus\|Vaccine Kim JW, Front Immunol 2023;14():1271508 SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 SARS-CoV-2_virus\|Vaccine Ku MW, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma Lee KS, bioRxiv 2022;(): Pathology\|VOC_B.1.617.2_Delta Lee S, Nature 2021 Nov;599(7884):283-289 SARS-CoV-2_virus\|Treatment Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Li K, mBio 2021 Aug 31;12(4):e0097021 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Lin X, bioRxiv 2021 Dec;(): Gene\|Pathology\|SARS-CoV-2_virus Liu R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 SARS-CoV-2_virus\|Vaccine Li W, Cell Rep 2022 Jan 11;38(2):110210 SARS-CoV-2_virus\|Treatment\|Variant Lu A, Int J Mol Sci 2024 Feb 8;25(4): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Manangeeswaran M, Front Immunol 2022;13():919815 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Mao T, bioRxiv 2022;(): SARS-CoV-2_virus\|Vaccine Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 SARS-CoV-2_virus\|Treatment Mao T, Science 2022 Nov 25;378(6622):eabo2523 SARS-CoV-2_virus\|Vaccine Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Pathology\|SARS-CoV-2_virus Marx S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment Matchett WE, J Immunol 2021 Jun 30;(): SARS-CoV-2_virus\|Vaccine McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Infection\|SARS-CoV_virus Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Infection\|SARS-CoV-2_virus Mejia OR, bioRxiv 2021 Nov;(): Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Nagai M, Nat Commun 2023 Jun 30;14(1):3863 SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Natekar JP, bioRxiv 2022 Apr;(): Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Noy-Porat T, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment Noy-Porat T, iScience 2021 May 21;24(5):102479 SARS-CoV-2_virus\|Treatment Oktay E, Commun Biol 2023 Mar 23;6(1):308 SARS-CoV-2_virus\|Vaccine Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Pathology\|SARS-CoV-2_virus Olivarria GM, bioRxiv 2021 Nov;(): Pathology\|SARS-CoV-2_virus Oliveira VLS, Front Immunol 2024;15():1378591 Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Perez P, Front Immunol 2022;13():995235 SARS-CoV-2_virus\|Vaccine Perez P, Front Immunol 2023;14():1264323 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Puhl AC, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment Puhl AC, bioRxiv 2021 Dec;(): Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment Qin Z, Theranostics 2021;11(16):8076-8091 Pathology\|SARS-CoV-2_virus Radvak P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Infection\|SARS-CoV-2_virus Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Infection\|Pathology\|SARS-CoV-2_virus Robertson SJ, bioRxiv 2021 Sep;(): Infection\|SARS-CoV-2_virus Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 SARS-CoV-2_virus\|Treatment Salzer R, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Scaglione A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 SARS-CoV-2_virus\|Treatment Seehusen F, bioRxiv 2021 Apr;(): Pathology\|SARS-CoV-2_virus Shapira T, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Silvas J, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus Sims JJ, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Slamanig S, EBioMedicine 2024 Jun 6;105():105185 SARS-CoV-2_virus\|Vaccine Smeyne RJ, bioRxiv 2022 Feb;(): PASC\|SARS-CoV-2_virus Sohn SY, mBio 2021 Nov 2;():e0275621 SARS-CoV-2_virus\|Treatment Song E, J Exp Med 2021 Mar 1;218(3): Infection\|SARS-CoV-2_virus Soni DK, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 SARS-CoV-2_virus\|Vaccine Subramaniam S, bioRxiv 2021 Aug;(): Pathology\|SARS-CoV-2_virus Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Su P, Mol Brain 2022 Aug 9;15(1):71 SARS-CoV-2_virus\|Treatment Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 SARS-CoV-2_virus\|Treatment Syenina A, PLoS Biol 2022 May;20(5):e3001643 SARS-CoV-2_virus\|Vaccine Tada T, Cell Rep 2020 Dec 22;33(12):108528 SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Tarres-Frexas F, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Tatham L, bioRxiv 2022;(): Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Turan RD, Sci Rep 2021 Aug 4;11(1):15799 SARS-CoV-2_virus\|Vaccine Ullah i, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Ullah I, iScience 2024 Mar 15;27(3):109049 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta van Bergen J, JCI Insight 2023 Nov 8;8(21): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron VanBlargan LA, Immunity 2021 Aug 19;(): SARS-CoV-2_virus\|Treatment\|Variant Van Dyke MC, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Infection\|SARS-CoV-2_virus Venzon M, bioRxiv 2021 Jul;(): Pathology\|SARS-CoV-2_virus Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Pathology\|SARS-CoV-2_virus\|Vaccine Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Weiss S, Int J Mol Sci 2023 May 5;24(9): SARS-CoV-2_virus\|Treatment Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Winkler ES, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Winkler ES, Nat Immunol 2020 Aug 24;(): Infection\|Pathology\|SARS-CoV-2_virus Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Pathology\|VOC_B.1.617.2_Delta Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Zhang L, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 SARS-CoV-2_virus Zheng J, bioRxiv 2020 Aug 10;(): Pathology\|SARS-CoV-2_virus\|Treatment Zheng J, Nature 2021 Jan;589(7843):603-607 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 MERS-CoV_virus\|SARS-CoV_virus
B6.Cg-Tg(Syn1-ACE2)10Sig/LazarJ	MGI:6401204	congenic\|mutant strain\|transgenic										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6.Cg-Tg(Syn1-ACE2)10Sig/LazarJ congenic\|mutant strain\|transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6(Cg)-Tyr^c-2J/J	MGI:2163869	mutant strain\|spontaneous mutation										Scaglione A, Front Immunol 2021;12():719077	J:335910	SARS-CoV-2_virus\|Treatment\|Vaccine	B6(Cg)-Tyr^c-2J/J mutant strain\|spontaneous mutation			Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine
B6/JGpt-Ace2^em1Cd/Gpt	MGI:6424280	coisogenic\|endonuclease-mediated mutation\|mutant strain										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6/JGpt-Ace2^em1Cd/Gpt coisogenic\|endonuclease-mediated mutation\|mutant strain			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6/JGpt-Ace2^em1Cflox/Gpt	MGI:6424281	coisogenic\|endonuclease-mediated mutation\|mutant strain										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6/JGpt-Ace2^em1Cflox/Gpt coisogenic\|endonuclease-mediated mutation\|mutant strain			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6N.129-Ccr9^tm1Lov/JmfJ	MGI:5644060	congenic\|mutant strain\|targeted mutation										Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:308730 J:327836	Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	B6N.129-Ccr9^tm1Lov/JmfJ congenic\|mutant strain\|targeted mutation			Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
B6N.129-Ceacam1^tm2Bcn/J	MGI:5887126	congenic\|mutant strain\|targeted mutation										Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:92376	Infection\|Mouse_Hepatitis_virus	B6N.129-Ceacam1^tm2Bcn/J congenic\|mutant strain\|targeted mutation			Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
B6N.129S1-Tlr3^tm1Flv/J	MGI:4355732	congenic\|mutant strain\|targeted mutation	MGI:6433074	Tlr3^tm1Flv	MGI:2653138	Targeted	Null/knockout			immune system respiratory system	MP:0005387 MP:0005388	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	B6N.129S1-Tlr3^tm1Flv/J congenic\|mutant strain\|targeted mutation	MGI:6433074	immune system respiratory system	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
B6N.129S2-Casp1^tm1Flv/J	MGI:5004932	congenic\|mutant strain\|targeted mutation										Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yang J, Nature 2020 Jul 29;():	J:331762 J:323769 J:292665	Mouse_Hepatitis_virus Gene\|Pathology SARS-CoV-2_virus\|Vaccine	B6N.129S2-Casp1^tm1Flv/J congenic\|mutant strain\|targeted mutation			Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg	MGI:5521186	congenic\|mutant strain\|targeted mutation	MGI:5520923	Pla2g2d^tm1.1Mhg	MGI:5517549	Targeted	Null/knockout			cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0010768	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68	J:229035	Infection\|SARS-CoV-MA_virus	B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg congenic\|mutant strain\|targeted mutation	MGI:5520923	cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Infection\|SARS-CoV-MA_virus
B6NTac.129(FVB)-Muc4^tm1Unc/Rand	MGI:6423076	congenic\|mutant strain\|targeted mutation	MGI:6423102	Muc4^tm1Unc	MGI:6416171	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	growth/size/body immune system respiratory system mortality/aging	MP:0005378 MP:0005387 MP:0005388 MP:0010768	Plante JA, bioRxiv 2020;():	J:287566	Infection\|SARS-CoV-MA_virus\|Sex_bias	B6NTac.129(FVB)-Muc4^tm1Unc/Rand congenic\|mutant strain\|targeted mutation	MGI:6423102	growth/size/body immune system respiratory system mortality/aging Coronavirus infectious disease	Plante JA, bioRxiv 2020;(): Infection\|SARS-CoV-MA_virus\|Sex_bias
B6;SJL-Il6ra^tm1.1Drew/J	MGI:4461009	mutant stock\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6;SJL-Il6ra^tm1.1Drew/J mutant stock\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.SJL-Ptprc^a Pepc^b/BoyJ	MGI:2164701	congenic\|mutant strain										Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology\|SARS-CoV-2_virus	B6.SJL-Ptprc^a Pepc^b/BoyJ congenic\|mutant strain			Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus
B6;SJL-Tg(KRT18-DPP4)3Pbmj/J	MGI:6455170	mutant stock\|transgenic										Li K, J Infect Dis 2016 Mar 1;213(5):712-22	J:285467	Infection\|MERS-CoV_virus\|Pathology	B6;SJL-Tg(KRT18-DPP4)3Pbmj/J mutant stock\|transgenic			Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology
B6;SJL-Tg(SFTPC-DPP4)3Pbmj/J	MGI:6455169	mutant stock\|transgenic										Li K, J Infect Dis 2016 Mar 1;213(5):712-22	J:285467	Infection\|MERS-CoV_virus\|Pathology	B6;SJL-Tg(SFTPC-DPP4)3Pbmj/J mutant stock\|transgenic			Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology
BALB/c	MGI:2161072	strain family										Abdoli A, bioRxiv 2021 Jun;(): Abdoli A, bioRxiv 2022 Feb;(): Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Agostini ML, mBio 2018 Mar 6;9(2): Alimohammadi R, bioRxiv 2022 Mar;(): Amanat F, bioRxiv 2021 apr;(): Amanat F, bioRxiv 2021 Aug;(): An Y, bioRxiv 2021 Mar;(): Ao Z, bioRxiv 2021 Dec;(): Baray JC, bioRxiv 2020;(): Barreiro A, bioRxiv 2021 Dec;(): Baxter VK, bioRxiv 2022 Feb;(): Bellier B, bioRxiv 2021 Sep;(): Borriello F, bioRxiv 2021 Sep;(): Brentville VA, bioRxiv 2021 Jun;(): Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Capone S, bioRxiv 2020 Oct;(): Castano-Rodriguez C, mBio 2018 May 22;9(3): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chapman AP, bioRxiv 2020;(): Chen C, bioRxiv 2022 Feb;(): Chen J, bioRxiv 2021 Nov;(): Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 Chevillard C, bioRxiv 2021 Sep;(): Choque-Guevara R, bioRxiv 2021 Nov;(): Cohen AA, Science 2021 Feb 12;371(6530):735-741 Compton SR, Virology 1994 Aug 15;203(1):197-201 Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Dai L, Cell 2020 Jun 28;(): Dangi T, bioRxiv 2021 Jun;(): Davenport BJ, bioRxiv 2021 Nov;(): Day CW, Virology 2009 Dec 20;395(2):210-22 Deming D, PLoS Med 2006 Dec;3(12):e525 de Wilde AH, Virus Res 2017 Jan 15;228():7-13 Dey A, bioRxiv 2021 Jan;(): Dietert K, PLoS One 2017;12(11):e0188251 Du L, Nat Commun 2016 Nov 22;7():13473 Du L, PLoS One 2013;8(12):e81587 Elia U, bioRxiv 2020;(): Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Fehr AR, mBio 2016 Dec 13;7(6): Feng L, Nat Commun 2020 Aug 21;11(1):4207 Fernandez-Castaneda A, bioRxiv 2022;(): Ferrantelli F, bioRxiv 2020 Dec;(): Fett C, J Virol 2013 Jun;87(12):6551-9 Fu D, PLoS Biol 2021 May;19(5):e3001209 Gao J, bioRxiv 2021 Apr;(): Gao Q, Science 2020 Jul 3;369(6499):77-81 Gawish R, bioRxiv 2021 Aug;(): Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): Graham RL, Commun Biol 2018;1():179 Gu H, bioRxiv 2020;(): Gu H, Science 2020 Jul 30;(): Guo X, Immunology 2015 Aug;145(4):476-84 Guo Y, J Biol Chem 2021 Jan 29;():100346 Haabeth OAW, bioRxiv 2021 Apr;(): He Z, bioRxiv 2020;(): Huang Q, Nat Commun 2021 Feb 3;12(1):776 Hua X, JCI Insight 2018 Jun 7;3(11): Hwang M, Immunology 2015 Mar;144(3):374-386 Jangra S, bioRxiv 2020 Oct 23;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Kalnin KV, bioRxiv 2020;(): Kandeil A, PLoS One 2020;15(10):e0241471 Kang YF, bioRxiv 2020 Nov;(): Kato H, PLoS One 2019;14(10):e0223684 Khan MS, bioRxiv 2022 May;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kibler KV, bioRxiv 2021 Dec;(): Kim E, EBioMedicine 2020 May;55():102743 Kim MH, PLoS One 2019;14(7):e0220196 Kobiyama K, bioRxiv 2021 Mar;(): Kozlovskaya L, bioRxiv 2022 Feb;(): Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 Lan J, PLoS One 2014;9(11):e112602 Lapp SA, bioRxiv 2021 Apr;(): Liang Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): Li D, bioRxiv 2021 Jan;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Li L, bioRxiv 2020 Dec;(): Li L, bioRxiv 2021 Jul;(): Lin WS, bioRxiv 2021 Nov;(): Lin X, bioRxiv 2021 Sep;(): Li SW, Sci Rep 2016 May 13;6():25754 Liu H, bioRxiv 2021 Oct;(): Liu S, bioRxiv 2022 Feb;(): Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 Liu X, bioRxiv 2021 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Liu YM, Cell Rep 2020 Aug 11;32(6):108016 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Li Y, bioRxiv 2020 Oct;(): Li Z, bioRxiv 2021 Aug;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Luo S, bioRxiv 2020;(): Lu RM, bioRxiv 2022 Apr;(): Lu S, bioRxiv 2022 Feb;(): Lv H, Cell Rep 2020 Jun 2;31(9):107725 Mamedov T, bioRxiv 2022 Apr;(): Martinez DR, Science 2021 Aug 27;373(6558):991-998 Mazumder S, bioRxiv 2020 Oct;(): McMillan CL, bioRxiv 2021 May;(): Menachery VD, J Virol 2018 Sep 1;92(17): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Mudrick HE, bioRxiv 2021 Apr;(): Muruato A, bioRxiv 2021 May;(): Nagai M, bioRxiv 2020 Dec;(): Nanishi E, bioRxiv 2021 May;(): Narayan R, bioRxiv 2022 Feb;(): Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 Niu J, Antiviral Res 2020 Jan;173():104646 Norheim G, bioRxiv 2020 Dec;(): O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 Park JG, bioRxiv 2021 Jan;(): Paschall AV, bioRxiv 2021;(): Petras M, bioRxiv 2020 Nov;(): Phatarphekar A, bioRxiv 2022 Jan;(): Pitcovski J, bioRxiv 2021 Jun;(): Pollet J, bioRxiv 2020 Nov;(): Pollet J, bioRxiv 2021 Jul;(): Qu L, bioRxiv 2021 Mar;(): Rappaport AR, bioRxiv 2021 Nov;(): Rauch S, bioRxiv 2020 Oct;(): Reed CC, bioRxiv 2021 Aug;(): Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Salah S, bioRxiv 2022 May;(): Schafer A, bioRxiv 2021 Sep;(): Scheiblhofer S, bioRxiv 2021 Feb;(): Seephetdee C, bioRxiv 2022 Mar;(): Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 Seo YB, bioRxiv 2020;(): Seo YB, bioRxiv 2021 Nov;(): Shen L, J Virol 2019 Jun 15;93(12): Shi Y, J Virol 2021 Jan 7;(): Shoemaker RH, bioRxiv 2021 Sep;(): Somogyi E, bioRxiv 2020;(): Staquicini DI, bioRxiv 2021 Mar;(): Stark FC, bioRxiv 2022 Mar;(): Su D, bioRxiv 2021 May;(): Su D, bioRxiv 2022 May;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Sun S, bioRxiv 2020 Nov;(): Sun W, bioRxiv 2021 Jul;(): Sun Y, bioRxiv 2021 Jun;(): Sun YJ, bioRxiv 2021 Jan;(): Swart M, bioRxiv 2022 Mar;(): Tostanoski LH, bioRxiv 2021 Jun;(): Tscherne A, bioRxiv 2021 Jan;(): Tseng CT, PLoS One 2012;7(4):e35421 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Unoh Y, bioRxiv 2022;(): Valdes-Balbin Y, bioRxiv 2021 Feb;(): Vogel AB, bioRxiv 2020 Dec;(): Walls AC, bioRxiv 2021 Mar;(): Walls AC, bioRxiv 2022 Feb;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wang J, Protein Cell 2020 Aug 4;(): Wen HJ, bioRxiv 2021 Apr;(): Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 White KM, Science 2021 Feb 26;371(6532):926-931 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Wu K, bioRxiv 2021 Apr;(): Wu S, Nat Commun 2020 Aug 14;11(1):4081 Wu Y, bioRxiv 2022 Mar;(): Xu K, bioRxiv 2021 Feb;(): Yang R, EBioMedicine 2020 Jul 21;58():102890 Yang Y, bioRxiv 2021 Jun;(): Yuan Y, bioRxiv 2022 Feb;(): Yu J, bioRxiv 2021 Nov;(): Zabaleta N, bioRxiv 2021 Jan;(): Zang J, bioRxiv 2022 Feb;(): Zhang C, Nat Commun 2021 Jan 11;12(1):264 Zhang H, bioRxiv 2021-08;(): Zhang YN, bioRxiv 2021 Mar;(): Zhao H, Nat Commun 2020 Aug 25;11(1):4252 Zhao H, Sci Rep 2016 Feb 25;6():22008 Zhao S, bioRxiv 2021 May;(): Zhou R, bioRxiv 2021 Oct;(): Zhou Y, Antiviral Res 2015 Apr;116():76-84 Zhuang Z, J Exp Med 2021 Apr 5;218(4): Zhu L, bioRxiv 2020 Nov;():	J:308653 J:321881 J:288639 J:291893 J:321926 J:304606 J:308583 J:302915 J:316767 J:295383 J:315723 J:321901 J:310112 J:310116 J:308658 J:297122 J:296388 J:291880 J:291593 J:296213 J:321898 J:315718 J:302246 J:302247 J:310119 J:315730 J:302244 J:19444 J:308652 J:316771 J:290261 J:308670 J:315715 J:288585 J:291598 J:286954 J:300435 J:291595 J:291617 J:291630 J:296197 J:291885 J:291863 J:300090 J:321759 J:299089 J:286952 J:308893 J:304619 J:291884 J:308587 J:324918 J:291631 J:295389 J:291864 J:291591 J:309633 J:304646 J:296195 J:302315 J:291882 J:291592 J:296553 J:308668 J:308726 J:296200 J:296974 J:296698 J:292831 J:325024 J:161935 J:316772 J:291871 J:291633 J:302719 J:321880 J:288030 J:291637 J:308711 J:308659 J:308661 J:299105 J:313329 J:298266 J:308625 J:313449 J:310109 J:291621 J:313441 J:321875 J:291594 J:302147 J:321879 J:300093 J:299936 J:296372 J:309204 J:27269 J:295380 J:324952 J:321856 J:291886 J:325040 J:309691 J:296690 J:308889 J:291883 J:291897 J:303189 J:304681 J:308714 J:299071 J:308734 J:321883 J:291590 J:290254 J:298264 J:288029 J:299311 J:311912 J:296700 J:321755 J:308650 J:296705 J:308626 J:302934 J:315716 J:296387 J:308727 J:286408 J:324943 J:310117 J:302702 J:321929 J:291879 J:296069 J:313450 J:291875 J:300108 J:310120 J:296196 J:302940 J:321920 J:308731 J:324975 J:322631 J:298260 J:296709 J:308630 J:308645 J:299309 J:321921 J:308654 J:299308 J:291628 J:309630 J:321771 J:302155 J:298269 J:302930 J:321874 J:328107 J:291872 J:304675 J:286327 J:303457 J:25438 J:331760 J:304684 J:304623 J:300088 J:321907 J:302149 J:291894 J:308671 J:321891 J:313463 J:299310 J:321848 J:300884 J:308588 J:303460 J:300091 J:286403 J:308891 J:313436 J:288032 J:308898 J:298147	SARS-CoV-2_virus\|Vaccine Vaccine\|VOC_B.1.1.529_Omicron Infection SARS-CoV-MA_virus\|Treatment SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2-MA_virus\|Vaccine Infection\|SARS-CoV-2_virus Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus\|Sex_bias SARS-CoV-2_virus SARS-CoV-2-MA_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV_virus\|Vaccine Vaccine SARS-CoV-2_virus\|Treatment Infection\|Mouse_Hepatitis_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Pathology\|SARS-CoV-MA_virus MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Pathology MERS-CoV_virus\|Vaccine Pathology\|SARS-CoV-2_virus SARS-CoV-MA_virus\|Vaccine SARS-CoV-2-MA_virus SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2-MA_virus Infection\|SARS-CoV-MA_virus\|Vaccine Infection\|Mouse_Hepatitis_virus\|SARS-CoV-MA_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta MERS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.617.2_Delta Infection\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2-MA_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Variant HCoV-OC43_virus\|Infection\|SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|SARS-CoV-MA_virus SARS-CoV-MA_virus HCoV-OC43_virus\|Infection HCoV-229E_virus\|SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta HCoV-OC43_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Treatment\|VOC_P.1_Gamma Vaccine\|Variant SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Infection\|SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV_virus\|Treatment Infection\|MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	BALB/c strain family			Abdoli A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Abdoli A, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Infection Agostini ML, mBio 2018 Mar 6;9(2): SARS-CoV-MA_virus\|Treatment Alimohammadi R, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine Amanat F, bioRxiv 2021 apr;(): SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Amanat F, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma An Y, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Ao Z, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Baray JC, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Barreiro A, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Baxter VK, bioRxiv 2022 Feb;(): SARS-CoV-2-MA_virus\|Vaccine Bellier B, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Infection\|SARS-CoV-2_virus Capone S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Castano-Rodriguez C, mBio 2018 May 22;9(3): Infection\|SARS-CoV-MA_virus Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 SARS-CoV-MA_virus\|Sex_bias Chapman AP, bioRxiv 2020;(): SARS-CoV-2_virus Chen C, bioRxiv 2022 Feb;(): SARS-CoV-2-MA_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 SARS-CoV_virus\|Vaccine Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 SARS-CoV_virus\|Vaccine Chevillard C, bioRxiv 2021 Sep;(): Vaccine Choque-Guevara R, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Cohen AA, Science 2021 Feb 12;371(6530):735-741 SARS-CoV-2_virus\|Treatment Compton SR, Virology 1994 Aug 15;203(1):197-201 Infection\|Mouse_Hepatitis_virus Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Coria LM, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Dai L, Cell 2020 Jun 28;(): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Davenport BJ, bioRxiv 2021 Nov;(): MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Day CW, Virology 2009 Dec 20;395(2):210-22 Pathology\|SARS-CoV-MA_virus Deming D, PLoS Med 2006 Dec;3(12):e525 SARS-CoV_virus\|Vaccine de Wilde AH, Virus Res 2017 Jan 15;228():7-13 MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Dey A, bioRxiv 2021 Jan;(): Vaccine Dietert K, PLoS One 2017;12(11):e0188251 MERS-CoV_virus\|Pathology Du L, Nat Commun 2016 Nov 22;7():13473 MERS-CoV_virus\|Vaccine Du L, PLoS One 2013;8(12):e81587 MERS-CoV_virus\|Vaccine Elia U, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): SARS-CoV-2_virus\|Vaccine Fehr AR, mBio 2016 Dec 13;7(6): Infection\|SARS-CoV-MA_virus Feng L, Nat Commun 2020 Aug 21;11(1):4207 SARS-CoV-2_virus\|Vaccine Fernandez-Castaneda A, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Ferrantelli F, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Fett C, J Virol 2013 Jun;87(12):6551-9 SARS-CoV-MA_virus\|Vaccine Fu D, PLoS Biol 2021 May;19(5):e3001209 SARS-CoV-2_virus\|Treatment Gao J, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Gao Q, Science 2020 Jul 3;369(6499):77-81 SARS-CoV-2_virus\|Vaccine Gawish R, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Graham RL, Commun Biol 2018;1():179 SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Gu H, bioRxiv 2020;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Gu H, Science 2020 Jul 30;(): Infection\|SARS-CoV-MA_virus\|Vaccine Guo X, Immunology 2015 Aug;145(4):476-84 MERS-CoV_virus\|Vaccine Guo Y, J Biol Chem 2021 Jan 29;():100346 SARS-CoV-2_virus\|Treatment Haabeth OAW, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine He Z, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Huang Q, Nat Commun 2021 Feb 3;12(1):776 SARS-CoV-2_virus\|Vaccine Hua X, JCI Insight 2018 Jun 7;3(11): Infection\|Mouse_Hepatitis_virus\|SARS-CoV-MA_virus Hwang M, Immunology 2015 Mar;144(3):374-386 Mouse_Hepatitis_virus Jangra S, bioRxiv 2020 Oct 23;(): SARS-CoV-2_virus\|Vaccine Jiang S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Joyce MGl Chen WH, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Kalnin KV, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Kandeil A, PLoS One 2020;15(10):e0241471 SARS-CoV-2_virus Kang YF, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Kato H, PLoS One 2019;14(10):e0223684 MERS-CoV_virus\|Vaccine Khan MS, bioRxiv 2022 May;(): SARS-CoV-2_virus\|Vaccine Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Kibler KV, bioRxiv 2021 Dec;(): SARS-CoV-2-MA_virus\|Vaccine Kim E, EBioMedicine 2020 May;55():102743 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Kim MH, PLoS One 2019;14(7):e0220196 MERS-CoV_virus\|Vaccine Kobiyama K, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Kozlovskaya L, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 MERS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Lan J, PLoS One 2014;9(11):e112602 MERS-CoV_virus\|Vaccine Lapp SA, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Liang Y, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Liao HY, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Li D, bioRxiv 2021 Jan;(): SARS-CoV-2_virus Li K, mBio 2021 Aug 31;12(4):e0097021 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Li L, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Li L, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Lin WS, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Lin X, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Treatment Li SW, Sci Rep 2016 May 13;6():25754 SARS-CoV_virus Liu H, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.617.2_Delta Liu S, bioRxiv 2022 Feb;(): Infection\|VOC_B.1.1.529_Omicron Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 MERS-CoV_virus\|Vaccine Liu X, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Liu Y, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine Liu YM, Cell Rep 2020 Aug 11;32(6):108016 SARS-CoV-2_virus Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Li Y, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Treatment Li Z, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus\|Treatment Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Mouse_Hepatitis_virus Luo S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Lu RM, bioRxiv 2022 Apr;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Lu S, bioRxiv 2022 Feb;(): Variant Lv H, Cell Rep 2020 Jun 2;31(9):107725 HCoV-OC43_virus\|Infection\|SARS-CoV-2_virus\|SARS-CoV_virus Mamedov T, bioRxiv 2022 Apr;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Martinez DR, Science 2021 Aug 27;373(6558):991-998 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.351_Beta Mazumder S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine McMillan CL, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Menachery VD, J Virol 2018 Sep 1;92(17): SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Infection\|SARS-CoV-2_virus Montagutelli X, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Mudrick HE, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Muruato A, bioRxiv 2021 May;(): SARS-CoV-2_virus\|SARS-CoV-MA_virus Nagai M, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus Nanishi E, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Narayan R, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Treatment Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 SARS-CoV-MA_virus Niu J, Antiviral Res 2020 Jan;173():104646 HCoV-OC43_virus\|Infection Norheim G, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 HCoV-229E_virus\|SARS-CoV_virus\|Treatment Park JG, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Paschall AV, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Petras M, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Phatarphekar A, bioRxiv 2022 Jan;(): SARS-CoV-2_virus\|Vaccine Pitcovski J, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Pollet J, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Pollet J, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Qu L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Rappaport AR, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Rauch S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Reed CC, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Pathology\|SARS-CoV-MA_virus Salah S, bioRxiv 2022 May;(): SARS-CoV-2_virus\|Vaccine Schafer A, bioRxiv 2021 Sep;(): SARS-CoV-2-MA_virus\|Treatment Scheiblhofer S, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Seephetdee C, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 SARS-CoV-MA_virus\|Vaccine Seo YB, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Seo YB, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Shen L, J Virol 2019 Jun 15;93(12): HCoV-OC43_virus\|Treatment Shi Y, J Virol 2021 Jan 7;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Shoemaker RH, bioRxiv 2021 Sep;(): SARS-CoV-2-MA_virus\|Treatment Somogyi E, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Staquicini DI, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Stark FC, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Su D, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Su D, bioRxiv 2022 May;(): Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Sun S, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Sun S, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus Sun W, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Sun Y, bioRxiv 2021 Jun;(): Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Sun YJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus Swart M, bioRxiv 2022 Mar;(): Vaccine\|VOC_B.1.1.529_Omicron Tostanoski LH, bioRxiv 2021 Jun;(): SARS-CoV-2-MA_virus\|Vaccine Tscherne A, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Tseng CT, PLoS One 2012;7(4):e35421 SARS-CoV_virus\|Vaccine Turan RD, Sci Rep 2021 Aug 4;11(1):15799 SARS-CoV-2_virus\|Vaccine Unoh Y, bioRxiv 2022;(): Treatment\|VOC_P.1_Gamma Valdes-Balbin Y, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Vogel AB, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Walls AC, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Walls AC, bioRxiv 2022 Feb;(): Vaccine\|Variant Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Wang J, Protein Cell 2020 Aug 4;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Wen HJ, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 Infection\|SARS-CoV_virus White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection\|Mouse_Hepatitis_virus Wong LR, Nature 2022 May;605(7908):146-151 SARS-CoV-2-MA_virus\|Treatment WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Wu K, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Wu S, Nat Commun 2020 Aug 14;11(1):4081 SARS-CoV-2_virus\|Vaccine Wu Y, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Xu K, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Yang R, EBioMedicine 2020 Jul 21;58():102890 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Yang Y, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Yuan Y, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.617.2_Delta Yu J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Zabaleta N, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Zang J, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Zhang C, Nat Commun 2021 Jan 11;12(1):264 SARS-CoV-2_virus\|Treatment Zhang H, bioRxiv 2021-08;(): SARS-CoV-2_virus\|Treatment Zhang YN, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Zhao H, Nat Commun 2020 Aug 25;11(1):4252 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment Zhao H, Sci Rep 2016 Feb 25;6():22008 MERS-CoV_virus\|SARS-CoV_virus\|Treatment Zhao S, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Zhou R, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Vaccine Zhou Y, Antiviral Res 2015 Apr;116():76-84 Infection\|MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Zhuang Z, J Exp Med 2021 Apr 5;218(4): Infection\|SARS-CoV-2_virus Zhu L, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment
BALB/cAnNCr	MGI:2160915	inbred strain										DeDiego ML, J Virol 2014 Jan;88(2):913-24 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:286180 J:153918	Pathology\|SARS-CoV-MA_virus\|Treatment Mouse_Hepatitis_virus\|Pathology	BALB/cAnNCr inbred strain			DeDiego ML, J Virol 2014 Jan;88(2):913-24 Pathology\|SARS-CoV-MA_virus\|Treatment Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
BALB/cAnNCrl	MGI:2683685	inbred strain										Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Frieman M, J Virol 2012 Jan;86(2):884-97 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Polak K, bioRxiv 2020 Oct;(): Ying B, bioRxiv 2022 Feb;():	J:288314 J:303464 J:288107 J:288640 J:286329 J:296676 J:321873	SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus\|Treatment Infection\|SARS-CoV-MA_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Vaccine\|VOC_B.1.1.529_Omicron	BALB/cAnNCrl inbred strain			Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 SARS-CoV_virus\|Treatment Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 SARS-CoV-2_virus\|Vaccine Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Frieman M, J Virol 2012 Jan;86(2):884-97 Infection\|SARS-CoV-MA_virus Jia W, Emerg Microbes Infect 2019;8(1):760-772 MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Polak K, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron
BALB/cAnNHsd	MGI:2161082	inbred strain										Adams LE, Cell Rep 2023 Mar 30;42(4):112326 Bolles M, J Virol 2011 Dec;85(23):12201-15 Leist SR, Cell 2020 Sep 23;(): Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Roberts A, Virus Res 2008 Apr;133(1):20-32 Rockx B, J Virol 2009 Jul;83(14):7062-74 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8	J:349062 J:288593 J:296277 J:286371 J:286331 J:286406 J:286332 J:36900 J:64200	SARS-CoV-2-MA_virus\|Vaccine SARS-CoV_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2-MA_virus Infection Infection\|SARS-CoV_virus\|Vaccine Pathology\|SARS-CoV_virus SARS-CoV_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	BALB/cAnNHsd inbred strain			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine Bolles M, J Virol 2011 Dec;85(23):12201-15 SARS-CoV_virus\|Vaccine Leist SR, Cell 2020 Sep 23;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Infection Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Rockx B, J Virol 2009 Jul;83(14):7062-74 Pathology\|SARS-CoV_virus Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 Mouse_Hepatitis_virus\|Pathology
BALB/cAnNTac	MGI:6200629	inbred strain										Adams LE, Cell Rep 2023 Mar 30;42(4):112326 Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Roberts A, J Virol 2005 May;79(9):5833-8 Subbarao K, J Virol 2004 Apr;78(7):3572-7	J:349062 J:288263 J:299104 J:303465 J:286301 J:286300	SARS-CoV-2-MA_virus\|Vaccine SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine Pathology\|SARS-CoV_virus SARS-CoV_virus	BALB/cAnNTac inbred strain			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 SARS-CoV_virus\|Treatment Liu R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 SARS-CoV-2_virus\|Vaccine Roberts A, J Virol 2005 May;79(9):5833-8 Pathology\|SARS-CoV_virus Subbarao K, J Virol 2004 Apr;78(7):3572-7 SARS-CoV_virus
BALB/cBy	MGI:2159790	inbred strain										Bolles M, J Virol 2011 Dec;85(23):12201-15	J:288593	SARS-CoV_virus\|Vaccine	BALB/cBy inbred strain			Bolles M, J Virol 2011 Dec;85(23):12201-15 SARS-CoV_virus\|Vaccine
BALB/cByJ	MGI:2159771	inbred strain										Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Walls AC, Cell Rep 2022 Aug 30;40(9):111299	J:14457 J:328107	Infection\|Mouse_Hepatitis_virus SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta	BALB/cByJ inbred strain			Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Infection\|Mouse_Hepatitis_virus Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta
BALB/cCrl	MGI:2386653	inbred strain										Kumaki Y, Antiviral Res 2017 Mar;139():1-12	J:286953	SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	BALB/cCrl inbred strain			Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
BALB/cCrSlc	MGI:2161019	inbred strain										Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 Nagai M, mBio 2021 Aug 31;12(4):e0159821	J:288033 J:313440	SARS-CoV-MA_virus\|Vaccine SARS-CoV-2_virus\|Vaccine	BALB/cCrSlc inbred strain			Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 SARS-CoV-MA_virus\|Vaccine Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus\|Vaccine
BALB/cJ	MGI:2159737	inbred strain										Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Arevalo AP, bioRxiv 2020 Nov;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Dalvie NC, bioRxiv 2021 Mar;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gawish R, Elife 2022 Jan 13;11():e74623 Graham JB, iScience 2024 Mar 15;27(3):109103 Hassan AO, Cell 2020 Jun 10;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hu Q, bioRxiv 2022 Mar;(): Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Rujas E, bioRxiv 2020;(): Slamanig S, EBioMedicine 2024 Jun 6;105():105185 Sourimant J, bioRxiv 2021 May;(): Tummino TA, bioRxiv 2021 Mar;(): Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 Wang L, Nat Commun 2015 Jul 28;6():7712 Zost SJ, Nature 2020 Jul 15;():	J:308640 J:290255 J:296697 J:297398 J:302712 J:288204 J:318828 J:345413 J:290258 J:309629 J:321924 J:357765 J:296183 J:350298 J:308735 J:303456 J:298609 J:291618 J:291899	SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus\|Treatment MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology Pathology\|SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus Infection\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Gene\|Variant\|VOC_B.1.1.529_Omicron MERS-CoV_virus\|Vaccine SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment	BALB/cJ inbred strain			Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Alsoussi WB, J Immunol 2020 Jun 26;(): SARS-CoV-2_virus\|Treatment Arevalo AP, bioRxiv 2020 Nov;(): Mouse_Hepatitis_virus\|Treatment Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Dalvie NC, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus\|Vaccine Hu Q, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Gene\|Variant\|VOC_B.1.1.529_Omicron Rujas E, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Slamanig S, EBioMedicine 2024 Jun 6;105():105185 SARS-CoV-2_virus\|Vaccine Sourimant J, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Tummino TA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 SARS-CoV-2_virus\|Vaccine Wang L, Nat Commun 2015 Jul 28;6():7712 MERS-CoV_virus\|Vaccine Zost SJ, Nature 2020 Jul 15;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment
BALB/cJRj	MGI:6357755	inbred strain										Lapuente D, bioRxiv 2021 Aug;():	J:308581	SARS-CoV-2_virus\|Vaccine	BALB/cJRj inbred strain			Lapuente D, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine
(BALB/cJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865665	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(BALB/cJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
BALB/c-Kctd9^em1Beij	MGI:6382781	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6382782	Kctd9^em1Beij	MGI:6382731	Endonuclease-mediated	Null/knockout			hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0010768	Zhang X, Front Immunol 2019;10():744	J:281803	Mouse_Hepatitis_virus	BALB/c-Kctd9^em1Beij coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6382782	hematopoietic system homeostasis/metabolism immune system mortality/aging	Zhang X, Front Immunol 2019;10():744 Mouse_Hepatitis_virus
BALB/cN	MGI:2161229	inbred strain										Kovacech B, bioRxiv 2021 Jun;():	J:308649	SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	BALB/cN inbred strain			Kovacech B, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
BALB/cOlaHsd	MGI:3047778	inbred strain										DeDiego ML, J Virol 2014 Jan;88(2):913-24 Hachim MY, Front Immunol 2020;11():1372 Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 Rothen DA, bioRxiv 2021 Sep;(): Spencer AJ, bioRxiv 2021 Jan;(): Spencer AJ, bioRxiv 2021 Jun;(): van der Ley PA, bioRxiv 2021 Aug;(): van Doremalen N, Nature 2020 Oct;586(7830):578-582	J:286180 J:291898 J:291656 J:310118 J:302146 J:308644 J:309194 J:297406	Pathology\|SARS-CoV-MA_virus\|Treatment Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-MA_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta	BALB/cOlaHsd inbred strain			DeDiego ML, J Virol 2014 Jan;88(2):913-24 Pathology\|SARS-CoV-MA_virus\|Treatment Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 SARS-CoV-MA_virus Rothen DA, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Spencer AJ, bioRxiv 2021 Jun;(): Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta van der Ley PA, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine van Doremalen N, Nature 2020 Oct;586(7830):578-582 SARS-CoV-2_virus\|Vaccine
BALB/c-Tg(Rela-luc)31Xen/Tac	MGI:6438428	coisogenic\|mutant strain\|transgenic										Samsudin F, bioRxiv 2021 Nov;():	J:313448	Pathology\|SARS-CoV-2_virus	BALB/c-Tg(Rela-luc)31Xen/Tac coisogenic\|mutant strain\|transgenic			Samsudin F, bioRxiv 2021 Nov;(): Pathology\|SARS-CoV-2_virus
BXSB.129S2(B6)-Ifnar1^tm1Agt/DcrJ	MGI:6159256	congenic\|mutant strain\|recombinant inbred (RI)\|targeted mutation										Miner JJ, Cell Rep 2020 Nov 3;33(5):108339	J:300094	SARS-CoV-2_virus	BXSB.129S2(B6)-Ifnar1^tm1Agt/DcrJ congenic\|mutant strain\|recombinant inbred (RI)\|targeted mutation			Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus
C.129P2(B6)-Fcer1g^tm1Rav/Tac	MGI:6438695	congenic\|mutant strain\|targeted mutation										Adams LE, Cell Rep 2023 Mar 30;42(4):112326	J:349062	SARS-CoV-2-MA_virus\|Vaccine	C.129P2(B6)-Fcer1g^tm1Rav/Tac congenic\|mutant strain\|targeted mutation			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine
C.129P2-Myd88^tm1Aki/Obs	MGI:5577109	congenic\|mutant strain\|targeted mutation										Nagai M, mBio 2021 Aug 31;12(4):e0159821	J:313440	SARS-CoV-2_virus\|Vaccine	C.129P2-Myd88^tm1Aki/Obs congenic\|mutant strain\|targeted mutation			Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus\|Vaccine
C.129S2-Cd1^tm1Gru/J	MGI:2174232	congenic\|mutant strain\|targeted mutation										Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection\|SARS-CoV_virus	C.129S2-Cd1^tm1Gru/J congenic\|mutant strain\|targeted mutation			Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
C.129S7(B6)-Rag1^tm1Mom/J	MGI:2161492	congenic\|mutant strain\|targeted mutation										Mao T, bioRxiv 2021 Jun;():	J:308656	Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma	C.129S7(B6)-Rag1^tm1Mom/J congenic\|mutant strain\|targeted mutation			Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma
C.129X1-Ifng^tm1Yiw	MGI:6430486	congenic\|mutant strain\|targeted mutation	MGI:6430488	Ifng^tm1Yiw	MGI:3036127	Targeted	Null/knockout			homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005376 MP:0005387 MP:0005370 MP:0010768	Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77	J:91691	Infection\|Mouse_Hepatitis_virus\|Pathology	C.129X1-Ifng^tm1Yiw congenic\|mutant strain\|targeted mutation	MGI:6430488	homeostasis/metabolism immune system liver/biliary system mortality/aging	Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection\|Mouse_Hepatitis_virus\|Pathology
C3H/HeJ	MGI:2159741	inbred strain										Dhanyalayam D, bioRxiv 2021 Sep;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41	J:310121 J:161935	Comorbidity\|SARS-CoV-2_virus Mouse_Hepatitis_virus\|Pathology	C3H/HeJ inbred strain			Dhanyalayam D, bioRxiv 2021 Sep;(): Comorbidity\|SARS-CoV-2_virus Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology
C3H/HeJCr	MGI:2165380	inbred strain										Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:291635 J:153918	Mouse_Hepatitis_virus\|Pathology	C3H/HeJCr inbred strain			Hartwig SM, PLoS One 2014;9(3):e90720 Mouse_Hepatitis_virus\|Pathology Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C3H/HeNCr	MGI:2160592	inbred strain										Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:291635 J:153918	Mouse_Hepatitis_virus\|Pathology	C3H/HeNCr inbred strain			Hartwig SM, PLoS One 2014;9(3):e90720 Mouse_Hepatitis_virus\|Pathology Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C3H/St	MGI:2159861	inbred strain										De Albuquerque N, J Virol 2006 Nov;80(21):10382-94	J:288204	Mouse_Hepatitis_virus\|Pathology	C3H/St inbred strain			De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology
C57BL/10ScNJ	MGI:2165217	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Kumaki Y, Antiviral Res 2017 Mar;139():1-12	J:153918 J:286953	Mouse_Hepatitis_virus\|Pathology SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	C57BL/10ScNJ inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
C57BL/10SnJ	MGI:2159909	inbred strain										Greer CD, bioRxiv 2021 Aug;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:308745 J:153918	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology	C57BL/10SnJ inbred strain			Greer CD, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C57BL/6	MGI:2159769	strain family										Ahan RE, bioRxiv 2021 Jul;(): Alimohammadi R, bioRxiv 2022 Mar;(): Almanza G, bioRxiv 2021;(): An Y, bioRxiv 2021 Mar;(): Bleau C, J Virol 2015 Oct;89(19):9896-908 Brechbuhl J, bioRxiv 2021 Mar;(): Brentville VA, bioRxiv 2021 Jun;(): Cao L, bioRxiv 2021;(): Castro JT, bioRxiv 2021 Sep;(): Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chen J, bioRxiv 2021 Nov;(): Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Counoupas C, bioRxiv 2020 Dec;(): Counoupas C, bioRxiv 2021;(): Dangi T, bioRxiv 2021 Jun;(): Dietert K, PLoS One 2017;12(11):e0188251 Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Ferrantelli F, bioRxiv 2020 Dec;(): Francis DM, bioRxiv 2021 Aug;(): Gale EC, bioRxiv 2021 Apr;(): Gale EC, bioRxiv 2021 Jul;(): Gawish R, bioRxiv 2021 Aug;(): Gerbre MS, bioRxiv 2021 Nov;(): Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Gray LT, bioRxiv 2021 May;(): Gu M, bioRxiv 2021 Apr;(): Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Hachim MY, Front Immunol 2020;11():1372 Hassler L, bioRxiv 2021 Mar;(): Hauser BM, bioRxiv 2021 Mar;(): Hawman DW, bioRxiv 2021 Dec;(): Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 He L, bioRxiv 2020;(): Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Jackson MR, bioRxiv 2021 Mar;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kim E, EBioMedicine 2020 May;55():102743 Kobiyama K, bioRxiv 2021 Mar;(): Koester ST, PLoS One 2021;16(3):e0248730 Lam JH, bioRxiv 2021 Jan;(): Lapuente D, bioRxiv 2021 Aug;(): Lartey NL, bioRxiv 2021 Apr;(): Lei L, PLoS One 2013;8(4):e61166 Liang Y, Zool Res 2020 Oct 12;():1-29 Li JQ, bioRxiv 2020 Oct;(): Li L, bioRxiv 2021 Jul;(): Liu A, J Pathol 2021 Jan;253(1):17-30 Liu J, bioRxiv 2021 May;(): Long Y, bioRxiv 2021 Apr;(): Luo S, bioRxiv 2020;(): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Nicolai L, bioRxiv 2021 Jun;(): Niu J, Antiviral Res 2020 Jan;173():104646 Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 Pan P, Nat Commun 2021 Aug 2;12(1):4664 Perez-Shibayama C, PLoS One 2013;8(11):e81442 Raha AA, Biosci Rep 2020 Dec 23;40(12): Ryu JK, bioRxiv 2021;(): Ryu S, bioRxiv 2020;(): Sanchez S, bioRxiv 2021 Apr;(): Seephetdee C, bioRxiv 2021 Mar;(): Soni S, PLoS One 2021;16(2):e0247510 Subramani J, bioRxiv 2021 Aug;(): Sun Y, bioRxiv 2021 Jun;(): Tong J, bioRxiv 2021 Feb;(): Tseng CT, PLoS One 2012;7(4):e35421 Volpatti LR, bioRxiv 2021 Apr;(): Vo T, bioRxiv 2020 Nov;(): Wang W, bioRxiv 2020 Dec;(): Wang Y, FASEB J 2021 Mar;35(3):e21419 Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Yang C, bioRxiv 2020;(): Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 Zabaleta N, bioRxiv 2021 Jan;(): Zhuang Z, J Exp Med 2021 Apr 5;218(4):	J:308572 J:321926 J:311920 J:302915 J:291878 J:303458 J:308658 J:311925 J:310123 J:302249 J:291593 J:315718 J:308652 J:316771 J:298265 J:308747 J:308670 J:291595 J:291885 J:299089 J:314179 J:303466 J:308622 J:308587 J:313462 J:88677 J:308736 J:303468 J:308901 J:291898 J:302921 J:302933 J:316766 J:300100 J:295372 J:297407 J:302315 J:302714 J:308668 J:308726 J:288028 J:161935 J:291871 J:302719 J:303461 J:300448 J:308581 J:304620 J:291629 J:296738 J:296674 J:308625 J:301197 J:308729 J:304618 J:295380 J:291897 J:303189 J:308623 J:290254 J:331805 J:313326 J:291632 J:313516 J:311923 J:295364 J:303470 J:302706 J:303459 J:308746 J:308645 J:302154 J:291628 J:304615 J:296710 J:299103 J:309535 J:291614 J:331760 J:304684 J:296070 J:291876 J:299310 J:308898	SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Infection\|Mouse_Hepatitis_virus Gene SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta SARS-CoV-MA_virus\|Sex_bias SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine MERS-CoV_virus\|Pathology SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus Pathology Treatment Mouse_Hepatitis_virus\|Pathology MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2_virus Comorbidity\|Gene Vaccine Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma HCoV-OC43_virus\|Infection SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha SARS-CoV_virus\|Vaccine Infection SARS-CoV-2-MA_virus\|Treatment	C57BL/6 strain family			Ahan RE, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Alimohammadi R, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine Almanza G, bioRxiv 2021;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta An Y, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Bleau C, J Virol 2015 Oct;89(19):9896-908 Infection\|Mouse_Hepatitis_virus Brechbuhl J, bioRxiv 2021 Mar;(): Gene Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Cao L, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Castro JT, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): SARS-CoV-2_virus\|Vaccine Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 SARS-CoV-MA_virus\|Sex_bias Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Coria LM, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Counoupas C, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Counoupas C, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Dietert K, PLoS One 2017;12(11):e0188251 MERS-CoV_virus\|Pathology Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): SARS-CoV-2_virus\|Vaccine Ferrantelli F, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Francis DM, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Gale EC, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Gale EC, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Gawish R, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus Gerbre MS, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Mouse_Hepatitis_virus Gray LT, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Gu M, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology\|SARS-CoV-2_virus Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Hassler L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Hauser BM, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Hawman DW, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus He L, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Gene Huang Q, Nat Commun 2021 Feb 3;12(1):776 SARS-CoV-2_virus\|Vaccine Jackson MR, bioRxiv 2021 Mar;(): Pathology Jiang S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Joyce MGl Chen WH, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Treatment Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Kim E, EBioMedicine 2020 May;55():102743 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Kobiyama K, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Koester ST, PLoS One 2021;16(3):e0248730 Gene Lam JH, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Lapuente D, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Lartey NL, bioRxiv 2021 Apr;(): Treatment Lei L, PLoS One 2013;8(4):e61166 Mouse_Hepatitis_virus Liang Y, Zool Res 2020 Oct 12;():1-29 Infection\|Pathology\|SARS-CoV-2_virus Li JQ, bioRxiv 2020 Oct;(): Treatment Li L, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Liu A, J Pathol 2021 Jan;253(1):17-30 Comorbidity\|Gene Liu J, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Long Y, bioRxiv 2021 Apr;(): Vaccine Luo S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Infection\|SARS-CoV-2_virus Montagutelli X, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Nicolai L, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Niu J, Antiviral Res 2020 Jan;173():104646 HCoV-OC43_virus\|Infection Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 SARS-CoV-2_virus\|Treatment Pan P, Nat Commun 2021 Aug 2;12(1):4664 Pathology\|SARS-CoV-2_virus Perez-Shibayama C, PLoS One 2013;8(11):e81442 Mouse_Hepatitis_virus Raha AA, Biosci Rep 2020 Dec 23;40(12): Gene Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment Ryu S, bioRxiv 2020;(): Mouse_Hepatitis_virus\|Pathology Sanchez S, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Seephetdee C, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Soni S, PLoS One 2021;16(2):e0247510 Gene Subramani J, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Sun Y, bioRxiv 2021 Jun;(): Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Tong J, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Tseng CT, PLoS One 2012;7(4):e35421 SARS-CoV_virus\|Vaccine Volpatti LR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Vo T, bioRxiv 2020 Nov;(): Infection Wang W, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Wang Y, FASEB J 2021 Mar;35(3):e21419 Gene Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Mouse_Hepatitis_virus Wong LR, Nature 2022 May;605(7908):146-151 SARS-CoV-2-MA_virus\|Treatment WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Yang C, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Zabaleta N, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Zhuang Z, J Exp Med 2021 Apr 5;218(4): Infection\|SARS-CoV-2_virus
C57BL/6-Ace2^{em1(ACE2)Yowa}	MGI:6431338	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6431340	Ace2^{em1(ACE2)Yowa}	MGI:6431336	Endonuclease-mediated	Humanized sequence\|Null/knockout\|Reporter	COVID-19	DOID:0080600	cardiovascular system homeostasis/metabolism immune system respiratory system	MP:0005385 MP:0005376 MP:0005387 MP:0005388	Sun SH, Cell Host Microbe 2020;20():1-10	J:288243	Infection\|Pathology\|SARS-CoV-2_virus	C57BL/6-Ace2^{em1(ACE2)Yowa} coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6431340	cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19	Sun SH, Cell Host Microbe 2020;20():1-10 Infection\|Pathology\|SARS-CoV-2_virus
C57BL/6(FVB)-Ceacam1^tm1.1Fta	MGI:5496838	mutant strain\|targeted mutation	MGI:5496535	Ceacam1^tm1.1Fta	MGI:5496530	Targeted	Inserted expressed sequence			immune system mortality/aging	MP:0005387 MP:0010768	Hirai A, J Virol 2010 Jul;84(13):6654-66	J:198335	Infection\|Mouse_Hepatitis_virus	C57BL/6(FVB)-Ceacam1^tm1.1Fta mutant strain\|targeted mutation	MGI:5496535	immune system mortality/aging	Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection\|Mouse_Hepatitis_virus
C57BL/6-Gt(ROSA)26Sor^{em1(DPP4)Yowa}	MGI:6403445	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6403447	Gt(ROSA)26Sor^{em1(DPP4)Yowa}	MGI:6403442	Endonuclease-mediated	Humanized sequence\|Inserted expressed sequence\|Reporter	Middle East respiratory syndrome	DOID:0080642	immune system nervous system	MP:0005387 MP:0003631	Fan C, Viruses 2018 Aug 23;10(9):	J:279060	Infection\|MERS-CoV_virus\|Pathology\|Treatment	C57BL/6-Gt(ROSA)26Sor^{em1(DPP4)Yowa} coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6403447	immune system nervous system Middle East respiratory syndrome	Fan C, Viruses 2018 Aug 23;10(9): Infection\|MERS-CoV_virus\|Pathology\|Treatment
C57BL/6-Irf5^tm1Ppr/J	MGI:5291921	coisogenic\|mutant strain\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	C57BL/6-Irf5^tm1Ppr/J coisogenic\|mutant strain\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
C57BL/6J	MGI:3028467	inbred strain	MGI:2166311							cardiovascular system endocrine/exocrine glands homeostasis/metabolism immune system muscle nervous system	MP:0005385 MP:0005379 MP:0005376 MP:0005387 MP:0005369 MP:0003631	Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Anand G, bioRxiv 2020 Dec;(): Benard A, Nat Commun 2021 Feb 18;12(1):1112 Biering SB, bioRxiv 2021 Dec;(): Bilinska K, bioRxiv 2021 Apr;(): Borriello F, bioRxiv 2021 Sep;(): Brady M, bioRxiv 2021 Aug;(): Brooks SD, bioRxiv 2021;(): Cao X, bioRxiv 2020 Dec;(): Chaparian RR, bioRxiv 2021 Apr;(): Chen JS, J Virol 2021 Jan 13;(): Chen Y, bioRxiv 2021 Nov;(): Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Das Sarma J, J Virol 2000 Oct;74(19):9206-13 De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Deng Q, bioRxiv 2020;(): Deng X, J Virol 2014 Oct 15;88(20):11886-98 dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Eldi P, bioRxiv 2021 Sep;(): Gawish R, Elife 2022 Jan 13;11():e74623 Geng T, bioRxiv 2021 Jun;(): Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, mBio 2013 Aug 6;4(4): Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Hachim MY, Front Immunol 2020;11():1372 Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Jia L, bioRxiv 2022 Feb;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Josset L, RNA Biol 2014;11(7):875-90 Khaddaj-Mallat R, bioRxiv 2021 May;(): Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 Kim TY, bioRxiv 2020 Dec;(): King RG, bioRxiv 2020;(): Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Leist SR, Cell 2020 Sep 23;(): Li S, JCI Insight 2021 Jan 25;6(2): Madar-Balakirski N, bioRxiv 2021 Jul;(): Mandal P, PLoS One 2021;16(7):e0246270 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Pewe L, J Virol 1997 Oct;71(10):7640-7 Radvak P, bioRxiv 2021 Jun;(): Roberts A, Virus Res 2008 Apr;133(1):20-32 Salvi V, bioRxiv 2021 Apr;(): Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Salzer R, bioRxiv 2021 May;(): Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Satta S, Theranostics 2022;12(6):2639-2657 Schafer A, mBio 2022 Aug 30;13(4):e0145422 Sepe S, bioRxiv 2021 Jun;(): Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Shirato K, bioRxiv 2021 Jul;(): Sims JJ, bioRxiv 2021 Apr;(): Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 Tsai SJ, bioRxiv 2020 Nov;(): Ullah I, iScience 2024 Mar 15;27(3):109049 Vanderheiden A, bioRxiv 2021 May;(): Vanderheiden A, mBio 2021 Nov 9;():e0274921 Wang H, bioRxiv 2021 Jul;(): Wang J, Protein Cell 2020 Aug 4;(): White KM, Science 2021 Feb 26;371(6532):926-931 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Xu H, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Zhuang X, iScience 2021 Oct 22;24(10):103144	J:308640 J:290255 J:298270 J:303473 J:316773 J:304622 J:310116 J:308577 J:311924 J:298259 J:308713 J:300110 J:315729 J:321761 J:325089 J:309512 J:297398 J:64499 J:288204 J:296182 J:214600 J:308662 J:310113 J:318828 J:308624 J:345413 J:288556 J:268979 J:291898 J:331824 J:33974 J:321887 J:303898 J:276026 J:308715 J:313327 J:299070 J:296068 J:286953 J:296277 J:302826 J:308635 J:308899 J:345954 J:42952 J:308643 J:286331 J:304651 J:313336 J:308749 J:309632 J:331825 J:327836 J:309195 J:286320 J:308576 J:304613 J:286332 J:322631 J:302250 J:296707 J:348954 J:308718 J:317454 J:308641 J:291872 J:303457 J:276183 J:295377 J:305777 J:341699	SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus Gene SARS-CoV-2_virus\|Vaccine Infection\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology SARS-CoV-2_virus\|Sex_bias Mouse_Hepatitis_virus Pathology\|SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus Infection\|Pathology\|SARS-CoV-MA_virus Infection\|SARS-CoV-MA_virus Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-MA_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Infection\|Pathology\|SARS-CoV-2-MA_virus Infection\|MERS-CoV-MA_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|SARS-CoV_virus\|Vaccine Comorbidity SARS-CoV-2_virus\|Variant SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus Comorbidity\|Gene MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Infection\|SARS-CoV-2-MA_virus\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Treatment	C57BL/6J inbred strain	MGI:2166311	cardiovascular system endocrine/exocrine glands homeostasis/metabolism immune system muscle nervous system	Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Alsoussi WB, J Immunol 2020 Jun 26;(): SARS-CoV-2_virus\|Treatment Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus Benard A, Nat Commun 2021 Feb 18;12(1):1112 SARS-CoV-2_virus Biering SB, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Bilinska K, bioRxiv 2021 Apr;(): Gene Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Brady M, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus Brooks SD, bioRxiv 2021;(): Gene Cao X, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus Chaparian RR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Chen JS, J Virol 2021 Jan 13;(): SARS-CoV-2_virus\|Treatment Chen Y, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Treatment Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Pathology\|SARS-CoV-2_virus Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Das Sarma J, J Virol 2000 Oct;74(19):9206-13 Mouse_Hepatitis_virus\|Pathology De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Deng Q, bioRxiv 2020;(): SARS-CoV-2_virus\|Sex_bias Deng X, J Virol 2014 Oct 15;88(20):11886-98 Mouse_Hepatitis_virus\|Pathology dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Mouse_Hepatitis_virus Eldi P, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Geng T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Infection\|Pathology\|SARS-CoV-2_virus Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus Jia L, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron Joag V, J Immunol 2021 Mar 1;206(5):931-935 SARS-CoV-2_virus\|Vaccine Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Khaddaj-Mallat R, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2_virus Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine Kim TY, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus King RG, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Leist SR, Cell 2020 Sep 23;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Li S, JCI Insight 2021 Jan 25;6(2): Pathology\|SARS-CoV-2_virus Madar-Balakirski N, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Mandal P, PLoS One 2021;16(7):e0246270 Mouse_Hepatitis_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Pewe L, J Virol 1997 Oct;71(10):7640-7 Mouse_Hepatitis_virus Radvak P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Salvi V, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 SARS-CoV-2_virus Salzer R, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Comorbidity Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus\|Variant Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Shirato K, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Sims JJ, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 SARS-CoV-2_virus\|Vaccine Tsai SJ, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Ullah I, iScience 2024 Mar 15;27(3):109049 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Vanderheiden A, bioRxiv 2021 May;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Vanderheiden A, mBio 2021 Nov 9;():e0274921 Infection\|SARS-CoV-2-MA_virus\|VOC_B.1.351_Beta Wang H, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Wang J, Protein Cell 2020 Aug 4;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus Xu H, bioRxiv 2020;(): Treatment Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus Zhuang X, iScience 2021 Oct 22;24(10):103144 SARS-CoV-2_virus
C57BL/6J-Ace2^em1Cya/Cya	MGI:6500741	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6500742	Ace2^em1Cya	MGI:6500740	Endonuclease-mediated	Null/knockout			cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282	J:299383	Gene	C57BL/6J-Ace2^em1Cya/Cya coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6500742	cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Gene
C57BL/6J-Ace2^em1Guru/Mmjax	MGI:6763024	coisogenic\|endonuclease-mediated mutation\|mutant strain										Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	C57BL/6J-Ace2^em1Guru/Mmjax coisogenic\|endonuclease-mediated mutation\|mutant strain			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
C57BL/6J-Ace2^em2Guru/Mmjax	MGI:6763026	coisogenic\|endonuclease-mediated mutation\|mutant strain										Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	C57BL/6J-Ace2^em2Guru/Mmjax coisogenic\|endonuclease-mediated mutation\|mutant strain			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
C57BL/6J-Dpp4^em1Rba	MGI:6400424	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6400425 MGI:6400427	Dpp4^em1Rba	MGI:6400423	Endonuclease-mediated	Humanized sequence	Middle East respiratory syndrome	DOID:0080642	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, PLoS One 2019;14(7):e0220126 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541):	J:279834 J:279723 J:286320	MERS-CoV_virus MERS-CoV_virus\|Pathology MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	C57BL/6J-Dpp4^em1Rba coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6400425 MGI:6400427	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 MERS-CoV_virus Leist SR, PLoS One 2019;14(7):e0220126 MERS-CoV_virus\|Pathology Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
C57BL/6JJcl	MGI:3055581	inbred strain										Nagai M, Nat Commun 2023 Jun 30;14(1):3863	J:337953	SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha	C57BL/6JJcl inbred strain			Nagai M, Nat Commun 2023 Jun 30;14(1):3863 SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha
C57BL/6J-Lyst^bg-J/J	MGI:2163994	coisogenic\|mutant strain\|spontaneous mutation										Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection\|SARS-CoV_virus	C57BL/6J-Lyst^bg-J/J coisogenic\|mutant strain\|spontaneous mutation			Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
C57BL/6JSmoc-Tg(CAG-ACE2,-luc)1Smoc/Smoc	MGI:6476454	coisogenic\|mutant strain\|transgenic										Yang S, J Med Virol 2022 Aug;94(8):3605-3612	J:339218	Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta	C57BL/6JSmoc-Tg(CAG-ACE2,-luc)1Smoc/Smoc coisogenic\|mutant strain\|transgenic			Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta
C57BL/6J-Sting1^gt/J	MGI:5292744	chemically induced mutation\|coisogenic\|mutant strain										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	C57BL/6J-Sting1^gt/J chemically induced mutation\|coisogenic\|mutant strain			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/J	MGI:6711187	coisogenic\|mutant strain\|transgenic										Tsai C-Y, bioRxiv 2021;():	J:305559	SARS-CoV-2_virus	C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/J coisogenic\|mutant strain\|transgenic			Tsai C-Y, bioRxiv 2021;(): SARS-CoV-2_virus
C57BL/6J-Ticam1^Lps2/J	MGI:3051113	chemically induced mutation\|coisogenic\|mutant strain	MGI:5520919	Ticam1^Lps2	MGI:2679794	Chemically induced (ENU)	Not Specified			cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	C57BL/6J-Ticam1^Lps2/J chemically induced mutation\|coisogenic\|mutant strain	MGI:5520919	cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
(C57BL/6J x C3H/HeJ)F1/J	MGI:5654213	F1 hybrid										Corbett KS, Nature 2020 Oct;586(7830):567-571	J:297398	MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine	(C57BL/6J x C3H/HeJ)F1/J F1 hybrid			Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine
C57BL/6-Mcph1^{Tg(HLA-A2.1)1Enge}/J	MGI:2164434	mutant strain\|transgenic										Carter B, bioRxiv 2021 May;():	J:308712	SARS-CoV-2_virus\|Vaccine	C57BL/6-Mcph1^{Tg(HLA-A2.1)1Enge}/J mutant strain\|transgenic			Carter B, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine
C57BL/6N	MGI:2159965	inbred strain										Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Rai P, bioRxiv 2021 Jun;():	J:297122 J:308665	Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus	C57BL/6N inbred strain			Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Infection\|SARS-CoV-2_virus Rai P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus
C57BL/6NCr	MGI:2160593	inbred strain										Fang Z, bioRxiv 2022 Mar;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:324933 J:153918	Vaccine\|VOC_B.1.1.529_Omicron Mouse_Hepatitis_virus\|Pathology	C57BL/6NCr inbred strain			Fang Z, bioRxiv 2022 Mar;(): Vaccine\|VOC_B.1.1.529_Omicron Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C57BL/6NCrl	MGI:2683688	inbred strain										De Gasparo R, bioRxiv 2021 Jan;(): Rujas E, bioRxiv 2020;(): Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474	J:300432 J:296183 J:298608	SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	C57BL/6NCrl inbred strain			De Gasparo R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Treatment Rujas E, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474 Mouse_Hepatitis_virus
C57BL/6NCrSlc	MGI:5295404	inbred strain										Nishikawa T, bioRxiv 2021 Jan;():	J:300443	SARS-CoV-2-MA_virus\|Vaccine	C57BL/6NCrSlc inbred strain			Nishikawa T, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|Vaccine
C57BL/6N-Gsdmd^em4Fcw/J	MGI:6196335	coisogenic\|endonuclease-mediated mutation\|mutant strain										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	C57BL/6N-Gsdmd^em4Fcw/J coisogenic\|endonuclease-mediated mutation\|mutant strain			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
C57BL/6NJ	MGI:3056279	inbred strain										Hachim MY, Front Immunol 2020;11():1372 Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:291898 J:308730 J:327836	Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	C57BL/6NJ inbred strain			Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/MbpMmucd	MGI:6346855	coisogenic\|mutant strain\|targeted mutation										Kerr CM, J Virol 2023 Sep 28;97(9):e0088523	J:340885	Gene\|Infection\|Mouse_Hepatitis_virus	C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/MbpMmucd coisogenic\|mutant strain\|targeted mutation			Kerr CM, J Virol 2023 Sep 28;97(9):e0088523 Gene\|Infection\|Mouse_Hepatitis_virus
C57BL/6NTac	MGI:2164831	inbred strain										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	C57BL/6NTac inbred strain			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
C57BL/6-Tg(Aicda/EGFP)1Rcas/J	MGI:5318090	coisogenic\|mutant strain\|transgenic										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	C57BL/6-Tg(Aicda/EGFP)1Rcas/J coisogenic\|mutant strain\|transgenic			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
C57BL/6-Tg(CAG-DPP4)4Yuzh	MGI:6402444	coisogenic\|mutant strain\|transgenic	MGI:6402445	Tg(CAG-DPP4)4Yuzh	MGI:6402443	Transgenic	Humanized sequence\|Inserted expressed sequence	Middle East respiratory syndrome	DOID:0080642	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging	MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Zhao G, PLoS One 2015;10(12):e0145561	J:286175	Infection\|MERS-CoV_virus	C57BL/6-Tg(CAG-DPP4)4Yuzh coisogenic\|mutant strain\|transgenic	MGI:6402445	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome	Zhao G, PLoS One 2015;10(12):e0145561 Infection\|MERS-CoV_virus
C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ	MGI:3706817	coisogenic\|mutant strain\|transgenic										Hohsfield LA, Glia 2022 May;70(5):875-891	J:324342	Mouse_Hepatitis_virus	C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ coisogenic\|mutant strain\|transgenic			Hohsfield LA, Glia 2022 May;70(5):875-891 Mouse_Hepatitis_virus
CAST/EiJ	MGI:2159793	inbred strain\|wild-derived	MGI:2659102							cellular immune system nervous system mortality/aging	MP:0005384 MP:0005387 MP:0003631 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	CAST/EiJ inbred strain\|wild-derived	MGI:2659102	cellular immune system nervous system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(CAST/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865669	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(CAST/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
C.B10-H2^b/LilMcdJ	MGI:2161599	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	C.B10-H2^b/LilMcdJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
CBA/J	MGI:2159756	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	CBA/J inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
CC001/Unc	MGI:6202009	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC001/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC001/UncJ	MGI:5649079	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC001/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC001/Unc x CC055/TauUnc)F1	MGI:7596177	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC001/Unc x CC055/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC001/Unc x CC074/Unc)F1	MGI:7596178	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC001/Unc x CC074/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC002/Unc	MGI:6188584	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC002/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC002/Unc x CC011/Unc)F1	MGI:7596179											Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC002/Unc x CC011/Unc)F1			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC002/Unc x CC021/Unc)F1	MGI:7596180	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC002/Unc x CC021/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC003/Unc	MGI:6188583	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:345413 J:270045	SARS-CoV-2-MA_virus Pathology\|SARS-CoV-MA_virus	CC003/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
(CC003/Unc x CC051/TauUnc)F1	MGI:7596181	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC003/Unc x CC051/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC003/Unc x CC062/Unc)F1	MGI:7596182	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC003/Unc x CC062/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC004/TauUnc	MGI:6188582	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC004/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC004/TauUncJ	MGI:5649082	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC004/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC004/TauUnc x CC011/Unc)F1	MGI:6307729	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC004/TauUnc x CC011/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC004/TauUnc x CC012/GeniUnc)F1	MGI:7596183	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC004/TauUnc x CC012/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC005/TauUnc	MGI:6188581	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC005/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC005/TauUnc x CC001/Unc)F1	MGI:6307730	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC001/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC005/TauUnc x CC038/GeniUnc)F1	MGI:7596184	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC005/TauUnc x CC040/TauUnc)F1	MGI:6307737	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC040/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC006/TauUnc	MGI:6188580	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC006/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC006/TauUncJ	MGI:5649237	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC006/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC006/TauUnc x CC007/Unc)F1	MGI:7596185	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC006/TauUnc x CC007/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC006/TauUnc x CC039/Unc)F1	MGI:7596186	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC006/TauUnc x CC039/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC007/Unc	MGI:6188579	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC007/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC007/Unc x CC070/TauUnc)F1	MGI:7596187	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC007/Unc x CC070/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC007/Unc x CC075/Unc)F1	MGI:7596188	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC007/Unc x CC075/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC008/GeniUnc	MGI:6188578	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC008/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC009/Unc)F1	MGI:7596189	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC010/GeniUnc)F1	MGI:7596190	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC010/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC018/Unc)F1	MGI:7596191	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC009/Unc	MGI:6188577	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC009/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC009/Unc x CC040/TauUnc)F1	MGI:7596192	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC009/Unc x CC040/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC010/GeniUnc	MGI:6188576	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC010/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC010/GeniUncJ	MGI:5649239	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC010/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC010/GeniUnc x CC015/Unc)F1	MGI:7596193	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC010/GeniUnc x CC015/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC010/GeniUnc x CC060/Unc)F1	MGI:7596194	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC010/GeniUnc x CC060/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC011/Unc	MGI:5749398	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:345413 J:327836	SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	CC011/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
CC011/UncJ	MGI:5649240	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC011/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC011/Unc x CC032/GeniUnc)F1	MGI:7596195	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC011/Unc x CC032/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC011/Unc x CC042/GeniUnc)F1	MGI:7596196	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC011/Unc x CC042/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC012/GeniUnc	MGI:6188575	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC012/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC012/GeniUncJ	MGI:5694080	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC012/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC012/GeniUnc x CC004/TauUnc)F1	MGI:7596198	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC012/GeniUnc x CC032/GeniUnc)F1	MGI:7596200											Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC032/GeniUnc)F1			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC012/GeniUnc x CC038/GeniUnc)F1	MGI:7596202	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC013/GeniUnc	MGI:6188574	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC013/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC013/GeniUncJ	MGI:5649241	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC013/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC013/GeniUnc x CC026/GeniUnc)F1	MGI:7596203	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC013/GeniUnc x CC026/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC013/GeniUnc x CC041/TauUnc)F1	MGI:7596204	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC013/GeniUnc x CC041/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC014/UncJ	MGI:5659477	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC014/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC014/Unc x CC059/TauUnc)F1	MGI:7596205	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC014/Unc x CC059/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC015/Unc	MGI:6188573	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC015/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC015/UncJ	MGI:5659478	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC015/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC015/Unc x CC018/Unc)F1	MGI:7596206	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC015/Unc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC015/Unc x CC059/TauUnc)F1	MGI:7596207	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC015/Unc x CC059/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC016/GeniUnc	MGI:6188572	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC016/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC016/GeniUncJ	MGI:5659479	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC016/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC016/GeniUnc x CC038/GeniUnc)F1	MGI:7596208	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC016/GeniUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC016/GeniUnc x CC061/GeniUnc)F1	MGI:7596209	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC016/GeniUnc x CC061/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC017/Unc	MGI:6188571	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:345413 J:327836	SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	CC017/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
(CC017/Unc x CC004/TauUnc)F1	MGI:6307731	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC017/Unc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC017/Unc x CC041/TauUnc)F1	MGI:7596210	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC017/Unc x CC041/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC018/Unc	MGI:6188570	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC018/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC018/UncJ	MGI:5649243	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC018/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC018/Unc x CC009/Unc)F1	MGI:7596211	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC018/Unc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC018/Unc x CC065/Unc)F1	MGI:7596212	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC018/Unc x CC065/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC019/TauUnc	MGI:6188569	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC019/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC019/TauUncJ	MGI:5649244	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC019/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC019/TauUnc x CC002/Unc)F1	MGI:7596213	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC019/TauUnc x CC004/TauUnc)F1	MGI:7596214	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC019/TauUnc x CC027/GeniUnc)F1	MGI:7596215	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC027/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC020/GeniUnc x CC008/GeniUnc)F1	MGI:7596216	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC020/GeniUnc x CC008/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC021/Unc	MGI:6188567	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC021/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC021/Unc x CC023/GeniUnc)F1	MGI:7596217	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC021/Unc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC022/GeniUnc x CC024/GeniUnc)F1	MGI:7596218	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC022/GeniUnc x CC024/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC022/GeniUnc x CC044/Unc)F1	MGI:7596219	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC022/GeniUnc x CC044/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC023/GeniUnc	MGI:6188565	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC023/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC023/GeniUncJ	MGI:5659483	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC023/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC023/GeniUnc x CC025/GeniUnc)F1	MGI:7596220	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC023/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC024/GeniUnc	MGI:6188564	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC024/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC024/GeniUncJ	MGI:5649245	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC024/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC024/GeniUnc x CC023/GeniUnc)F1	MGI:6307732	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC024/GeniUnc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC025/GeniUnc	MGI:6188563	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC025/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC025/GeniUncJ	MGI:5649246	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC025/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC025/GeniUnc x CC028/GeniUnc)F1	MGI:7596222	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC025/GeniUnc x CC028/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC026/GeniUnc	MGI:6188562	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC026/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC026/GeniUncJ	MGI:5649247	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC026/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC026/GeniUnc x CC034/Unc)F1	MGI:7596223	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC026/GeniUnc x CC034/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC027/GeniUnc	MGI:6188561	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC027/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC027/GeniUnc x CC036/Unc)F1	MGI:7596224	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC027/GeniUnc x CC036/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC027/GeniUnc x CC045/GeniUnc)F1	MGI:7596225	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC027/GeniUnc x CC045/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC028/GeniUnc	MGI:6188560	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC028/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC028/GeniUncJ	MGI:5659485	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC028/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC028/GeniUnc x CC024/GeniUnc)F1	MGI:7596226	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC028/GeniUnc x CC024/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC028/GeniUnc x CC030/GeniUnc)F1	MGI:7596227	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC028/GeniUnc x CC030/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC029/Unc	MGI:6188559	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC029/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC029/UncJ	MGI:5659486	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC029/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC029/Unc x CC027/GeniUnc)F1	MGI:7596228	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC029/Unc x CC027/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC029/Unc x CC071/TauUnc)F1	MGI:7596229	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC029/Unc x CC071/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC030/GeniUnc	MGI:6188558	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC030/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC030/GeniUncJ	MGI:5659487	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC030/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC030/GeniUnc x CC023/GeniUnc)F1	MGI:7596230	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC030/GeniUnc x CC042/GeniUnc)F1	MGI:7596231	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC042/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC030/GeniUnc x CC061/GeniUnc)F1	MGI:7596232	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC061/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC031/GeniUnc	MGI:6188557	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC031/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC032/GeniUnc	MGI:6188556	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC032/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC032/GeniUncJ	MGI:5649248	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC032/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC032/GeniUnc x CC013/GeniUnc)F1	MGI:7596233	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC032/GeniUnc x CC013/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC032/GeniUnc x CC017/Unc)F1	MGI:7596234	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC032/GeniUnc x CC017/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC033/GeniUnc	MGI:6188555	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC033/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC033/GeniUncJ	MGI:5659488	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC033/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC033/GeniUnc x CC046/Unc)F1	MGI:7596235	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC033/GeniUnc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC033/GeniUnc x CC068/TauUnc)F1	MGI:7596236	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC033/GeniUnc x CC068/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC034/Unc	MGI:6188554	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC034/Unc recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC034/Unc x CC016/GeniUnc)F1	MGI:7596237	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC034/Unc x CC016/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC035/Unc	MGI:6188553	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC035/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC035/Unc x CC020/GeniUnc)F1	MGI:7596238	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC035/Unc x CC020/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC035/Unc x CC071/TauUnc)F1	MGI:7596239	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC035/Unc x CC071/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC036/Unc	MGI:6188552	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC036/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC036/Unc x CC051/TauUnc)F1	MGI:7596240	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC036/Unc x CC051/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC037/TauUnc	MGI:6188551	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC037/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC037/TauUncJ	MGI:5649249	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC037/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC037/TauUnc x CC046/Unc)F1	MGI:7596242	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC037/TauUnc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC037/TauUnc x CC057/Unc)F1	MGI:7596243	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC037/TauUnc x CC057/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC038/GeniUnc	MGI:6188550	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC038/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC038/GeniUncJ	MGI:5659491	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC038/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC038/GeniUnc x CC013/GeniUnc)F1	MGI:7596244	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC038/GeniUnc x CC013/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC039/Unc	MGI:6188549	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC039/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC039/UncJ	MGI:5659492	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC039/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
CC040/TauUnc	MGI:6188548	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC040/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC040/TauUnc x CC003/Unc)F1	MGI:7596247	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC040/TauUnc x CC003/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC040/TauUnc x CC015/Unc)F1	MGI:7596248	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC040/TauUnc x CC015/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC041/TauUnc	MGI:6188547	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC041/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC041/TauUncJ	MGI:5649251	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC041/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC041/TauUnc x CC012/GeniUnc)F1	MGI:6307733	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC041/TauUnc x CC012/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC041/TauUnc x CC016/GeniUnc)F1	MGI:7596249	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC041/TauUnc x CC016/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC042/GeniUnc	MGI:6188546	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC042/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC042/GeniUncJ	MGI:5649255	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC042/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC042/GeniUnc x CC017/Unc)F1	MGI:7596250	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC017/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC042/GeniUnc x CC019/TauUnc)F1	MGI:7596251	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC019/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC042/GeniUnc x CC025/GeniUnc)F1	MGI:7596316	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC043/GeniUnc	MGI:6188545	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC043/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC043/GeniUncJ	MGI:5649256	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC043/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC043/GeniUnc x CC033/GeniUnc)F1	MGI:7596254	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC043/GeniUnc x CC033/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC043/GeniUnc x CC037/TauUnc)F1	MGI:7596257	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC043/GeniUnc x CC037/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC044/Unc	MGI:6188544	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC044/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC044/Unc x CC060/Unc)F1	MGI:7596258	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC044/Unc x CC060/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC045/GeniUnc	MGI:6188543	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC045/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC045/GeniUnc x CC044/Unc)F1	MGI:7596260	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC045/GeniUnc x CC044/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC046/Unc	MGI:6188542	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC046/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC046/UncJ	MGI:5659495	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC046/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC046/Unc x CC068/TauUnc)F1	MGI:7596262	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC046/Unc x CC068/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC049/TauUnc	MGI:6188540	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC049/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC049/TauUnc x CC036/Unc)F1	MGI:7596264	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC049/TauUnc x CC036/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC051/TauUnc	MGI:6188538	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC051/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC051/TauUnc x CC005/TauUnc)F1	MGI:7596265	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC051/TauUnc x CC005/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC051/TauUnc x CC009/Unc)F1	MGI:7596267	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC051/TauUnc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC052/GeniUncJ	MGI:5659498	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC052/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC052/GeniUnc x CC007/Unc)F1	MGI:7596268	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC052/GeniUnc x CC007/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC052/GeniUnc x CC014/Unc)F1	MGI:7596269	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC052/GeniUnc x CC014/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC053/Unc	MGI:6188536	recombinant inbred (RI)	MGI:6402903					severe acute respiratory syndrome	DOID:2945	immune system mortality/aging	MP:0005387 MP:0010768	Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:345413 J:270045	SARS-CoV-2-MA_virus Pathology\|SARS-CoV-MA_virus	CC053/Unc recombinant inbred (RI)	MGI:6402903	immune system mortality/aging severe acute respiratory syndrome	Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
CC055/TauUncJ	MGI:5659644	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC055/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC055/TauUnc x CC006/TauUnc)F1	MGI:7596270	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC055/TauUnc x CC006/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC055/TauUnc x CC028/GeniUnc)F1	MGI:7596271	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC055/TauUnc x CC028/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC056/GeniUncJ	MGI:5816616	mutant strain\|recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC056/GeniUncJ mutant strain\|recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC056/GeniUnc x CC033/GeniUnc)F1	MGI:7596272	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC056/GeniUnc x CC033/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC057/Unc	MGI:6188533	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC057/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC057/UncJ	MGI:5659646	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC057/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC057/Unc x CC052/GeniUnc)F1	MGI:7596273	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC057/Unc x CC052/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC058/Unc	MGI:6188532	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC058/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC058/UncJ	MGI:5659649	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC058/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC058/Unc x CC022/GeniUnc)F1	MGI:7596274	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC058/Unc x CC022/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC059/TauUnc	MGI:6188531	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC059/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC059/TauUncJ	MGI:5659650	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC059/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC059/TauUnc x CC065/Unc)F1	MGI:7596275	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC059/TauUnc x CC065/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC060/Unc	MGI:6188530	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC060/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC060/UncJ	MGI:5659652	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC060/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC060/Unc x CC006/TauUnc)F1	MGI:7596276	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC060/Unc x CC006/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC060/Unc x CC037/TauUnc)F1	MGI:7596277	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC060/Unc x CC037/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC061/GeniUnc	MGI:6188529	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC061/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC061/GeniUncJ	MGI:5649258	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC061/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC061/GeniUnc x CC025/GeniUnc)F1	MGI:7596278	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC061/GeniUnc x CC026/GeniUnc)F1	MGI:7596279	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC026/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC061/GeniUnc x CC039/Unc)F1	MGI:7596280	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC039/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC062/Unc	MGI:6188528	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC062/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC062/UncJ	MGI:5906018	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC062/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC062/Unc x CC046/Unc)F1	MGI:7596281	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC062/Unc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC062/Unc x CC072/TauUnc)F1	MGI:7596282	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC062/Unc x CC072/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC063/Unc x CC001/Unc)F1	MGI:7596283	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC063/Unc x CC001/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC063/Unc x CC002/Unc)F1	MGI:7596284	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC063/Unc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC065/Unc	MGI:6188526	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC065/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC065/UncJ	MGI:5659659	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC065/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC065/Unc x CC010/GeniUnc)F1	MGI:7596285	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC010/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC065/Unc x CC018/Unc)F1	MGI:7596286	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC065/Unc x CC072/TauUnc)F1	MGI:7596287	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC072/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC068/TauUnc	MGI:6188525	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC068/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC068/TauUncJ	MGI:5649259	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC068/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC068/TauUnc x CC035/Unc)F1	MGI:7596288	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC068/TauUnc x CC035/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC068/TauUnc x CC043/GeniUnc)F1	MGI:7596289	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC068/TauUnc x CC043/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC070/TauUnc x CC003/Unc)F1	MGI:7596290	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC070/TauUnc x CC003/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC071/TauUnc	MGI:6188523	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC071/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC071/TauUncJ	MGI:5659663	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC071/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC071/TauUnc x CC053/Unc)F1	MGI:7596291	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC071/TauUnc x CC053/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC071/TauUnc x CC058/Unc)F1	MGI:7596292	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC071/TauUnc x CC058/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC072/TauUnc	MGI:6188522	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC072/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC072/TauUnc x CC063/Unc)F1	MGI:7596293	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC072/TauUnc x CC063/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC072/TauUnc x CC075/Unc)F1	MGI:7596294	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC072/TauUnc x CC075/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC074/Unc	MGI:6188520	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC074/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC074/UncJ	MGI:5659666	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC074/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC074/Unc x CC002/Unc)F1	MGI:7596295	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC074/Unc x CC058/Unc)F1	MGI:7596296	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC058/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC074/Unc x CC062/Unc)F1	MGI:7596297	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC062/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC075/Unc	MGI:6188519	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC075/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC075/Unc x CC021/Unc)F1	MGI:7596298	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC075/Unc x CC021/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC075/Unc x CC035/Unc)F1	MGI:7596299	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC075/Unc x CC035/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC078/TauUnc	MGI:6188517	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC078/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC079/TauUnc	MGI:6188516	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC079/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC080/TauUnc	MGI:6188515	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC080/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC081/Unc	MGI:6188514	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC081/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC083/Unc	MGI:6188512	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC083/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC084/TauUnc	MGI:7596534	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC084/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
C.C3-H2^k/LilMcdJ	MGI:2163605	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	C.C3-H2^k/LilMcdJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C.Cg-Cd19^tm1(cre)Cgn Igh^b/J	MGI:2174231	congenic\|mutant strain\|targeted mutation										Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	C.Cg-Cd19^tm1(cre)Cgn Igh^b/J congenic\|mutant strain\|targeted mutation			Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
C.Cg-Tg(K18-ACE2)2Prlmn/J	MGI:6479852	congenic\|mutant strain\|transgenic										McCray PB Jr, J Virol 2007 Jan;81(2):813-21	J:283648	Infection\|SARS-CoV_virus	C.Cg-Tg(K18-ACE2)2Prlmn/J congenic\|mutant strain\|transgenic			McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Infection\|SARS-CoV_virus
CD-1	MGI:5649524	outbred stock										Borriello F, bioRxiv 2021 Sep;(): Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Dai W, Science 2020 Jun 19;368(6497):1331-1335 Duty JA, Med 2022 Oct 14;3(10):705-721.e11 Falach R, bioRxiv 2020 Nov;(): Fernandez-Castaneda A, bioRxiv 2022;(): Grandi A, bioRxiv 2021 Jul;(): Hassler L, bioRxiv 2021 Mar;(): King RG, bioRxiv 2020;(): Rice A, bioRxiv 2021 Mar;(): Rice A, bioRxiv 2021 Nov;(): Rice A, Sci Rep 2021 Jul 21;11(1):14917 Spencer AJ, bioRxiv 2021 Jan;(): Tummino TA, bioRxiv 2021 Mar;():	J:310116 J:302245 J:290792 J:349963 J:296678 J:321759 J:308639 J:302921 J:296068 J:303210 J:315738 J:308902 J:302146 J:303456	SARS-CoV-2_virus\|Vaccine Gene SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Comorbidity\|Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment	CD-1 outbred stock			Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Gene Dai W, Science 2020 Jun 19;368(6497):1331-1335 SARS-CoV_virus\|Treatment Duty JA, Med 2022 Oct 14;3(10):705-721.e11 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Falach R, bioRxiv 2020 Nov;(): Comorbidity\|Infection\|SARS-CoV-2_virus Fernandez-Castaneda A, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Grandi A, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Hassler L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment King RG, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Rice A, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Rice A, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Rice A, Sci Rep 2021 Jul 21;11(1):14917 SARS-CoV-2_virus\|Vaccine Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Tummino TA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment
CD1.129S-Stat1⁺/Cnbc	MGI:6119400	congenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.129S-Stat1⁺/Cnbc congenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1(129S)-Tg(ANPEP)270Mmul/Cnbc	MGI:6119398	congenic\|mutant strain\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1(129S)-Tg(ANPEP)270Mmul/Cnbc congenic\|mutant strain\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1(129S)-Tg(ANPEP)861Mmul/Cnbc	MGI:6119399	congenic\|mutant strain\|targeted mutation										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1(129S)-Tg(ANPEP)861Mmul/Cnbc congenic\|mutant strain\|targeted mutation			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv/Cnbc	MGI:6119401	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)270Mmul/Cnbc	MGI:6120539	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)270Mmul/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)861Mmul/Cnbc	MGI:6120528	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)861Mmul/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Crl:CD-1	MGI:5652673	outbred stock										Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8	J:36900 J:64200	Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	Crl:CD-1 outbred stock			Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 Mouse_Hepatitis_virus\|Pathology
DBA/1J	MGI:2159759	inbred strain										Shen ZT, Sci Rep 2016 Jun 28;6():28672	J:291625	SARS-CoV_virus	DBA/1J inbred strain			Shen ZT, Sci Rep 2016 Jun 28;6():28672 SARS-CoV_virus
DBA/2J	MGI:2684695	inbred strain										Hassan AO, Cell 2020 Jun 10;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:290258 J:153918	Infection\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus\|Pathology	DBA/2J inbred strain			Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
(DBA/2J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865662	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(DBA/2J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
FVB-Tg(Cdh5-tTA)D5Lbjn/J	MGI:4839338	coisogenic\|mutant strain\|transgenic										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	FVB-Tg(Cdh5-tTA)D5Lbjn/J coisogenic\|mutant strain\|transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
ICR	MGI:2160272	strain family										Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 Sagawa T, Environ Res 2021 Apr;195():110722 Spencer AJ, bioRxiv 2021 Jan;():	J:297098 J:305462 J:302146	SARS-CoV-2_virus\|Treatment Comorbidity\|Gene SARS-CoV-2_virus\|Vaccine	ICR strain family			Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 SARS-CoV-2_virus\|Treatment Sagawa T, Environ Res 2021 Apr;195():110722 Comorbidity\|Gene Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine
ICR-Tg(Ace2-ACE2)1Cqin/J	MGI:6401293	mutant stock\|transgenic										Yang XH, Comp Med 2007 Oct;57(5):450-9	J:141460	Infection\|SARS-CoV_virus	ICR-Tg(Ace2-ACE2)1Cqin/J mutant stock\|transgenic			Yang XH, Comp Med 2007 Oct;57(5):450-9 Infection\|SARS-CoV_virus
NOD.Cg-Prkdc^scid Il2rg^tm1Wjl Ace2^{tm1(ACE2)Dwnt}/J	MGI:6865656	congenic\|mutant strain\|spontaneous mutation\|targeted mutation										Zhou B, bioRxiv 2020;():	J:296356	Infection\|SARS-CoV-2_virus	NOD.Cg-Prkdc^scid Il2rg^tm1Wjl Ace2^{tm1(ACE2)Dwnt}/J congenic\|mutant strain\|spontaneous mutation\|targeted mutation			Zhou B, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus
NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/SzJ	MGI:3577020	congenic\|mutant strain\|spontaneous mutation\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/SzJ congenic\|mutant strain\|spontaneous mutation\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ	MGI:3804477	congenic\|targeted mutation										Halwe S, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308648 J:345954	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|MERS-CoV-MA_virus	NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ congenic\|targeted mutation			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
NOD/ShiLtJ	MGI:2162056	inbred strain										Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	NOD/ShiLtJ inbred strain			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(NOD/ShiLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865671	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(NOD/ShiLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
NZB/BlNJ	MGI:2180844	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	NZB/BlNJ inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
NZO/HlLtJ	MGI:2173835	inbred strain	MGI:5902927							immune system	MP:0005387	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	NZO/HlLtJ inbred strain	MGI:5902927	immune system	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(NZO/HlLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865670	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(NZO/HlLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
PWK/PhJ	MGI:2160654	inbred strain\|wild-derived	MGI:5902923							immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	PWK/PhJ inbred strain\|wild-derived	MGI:5902923	immune system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(PWK/PhJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865668	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(PWK/PhJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
SJL	MGI:2159833	strain family										Compton SR, Virology 1994 Aug 15;203(1):197-201	J:19444	Infection\|Mouse_Hepatitis_virus	SJL strain family			Compton SR, Virology 1994 Aug 15;203(1):197-201 Infection\|Mouse_Hepatitis_virus
SJL/J	MGI:2159739	inbred strain	MGI:3719417	Ceacam1^Hv2-r	MGI:3053078	Spontaneous				immune system	MP:0005387	Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Dveksler GS, J Virol 1993 Jan;67(1):1-8 Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Yokomori K, J Virol 1992 Dec;66(12):6931-8	J:14457 J:92495 J:25384 J:25438 J:3241	Infection\|Mouse_Hepatitis_virus Mouse_Hepatitis_virus	SJL/J inbred strain	MGI:3719417	immune system	Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Infection\|Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Mouse_Hepatitis_virus Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection\|Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus
STOCK Hopx^{tm2.1(cre/ERT2)Joe}/J	MGI:5320285	mutant stock\|targeted mutation										Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	STOCK Hopx^{tm2.1(cre/ERT2)Joe}/J mutant stock\|targeted mutation			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
STOCK Tg(Actl6b-Cre)4092Jiwu/J	MGI:5699265	mutant stock\|transgenic										Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	STOCK Tg(Actl6b-Cre)4092Jiwu/J mutant stock\|transgenic			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
STOCK Tg(Mx1-cre)1Cgn/J	MGI:2162199	mutant stock\|transgenic										Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226	J:331827	SARS-CoV-2_virus	STOCK Tg(Mx1-cre)1Cgn/J mutant stock\|transgenic			Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 SARS-CoV-2_virus
Swiss albino	MGI:5652853	outbred stock										Saleh AA, bioRxiv 2021 Mar;():	J:302705	SARS-CoV-2_virus\|Vaccine	Swiss albino outbred stock			Saleh AA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine
Swiss Webster	MGI:2160840	outbred stock										Lai CY, bioRxiv 2021 Mar;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Staquicini DI, bioRxiv 2021 Mar;():	J:302709 J:345954 J:302940	SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus	Swiss Webster outbred stock			Lai CY, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Staquicini DI, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine
WSB/EiJ	MGI:2160667	inbred strain\|wild-derived	MGI:5818477							immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	WSB/EiJ inbred strain\|wild-derived	MGI:5818477	immune system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(WSB/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865667	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(WSB/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus

Alleles for Laboratory Mouse Strains Used in Coronavirus Research

Alleles for laboratory mouse strains used in coronavirus research along with mouse phenotype categories and human disease terms and relevant references. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.

Mouse alleles names are linked to allele detail pages at MGI. Human disease terms are linked to the Disease Ontology Browser at MGI. References are linked to the reference detail pages at MGI.

1-allele	2-mgi	3-type	4-subtypes	5-geno-id	6-do-term	7-do-id	8-mp-term	9-mp-id	10-cite	11-jnum	12-tags	Allele	Genotype Details	Human Disease and Mouse Phenotype Categories	References \| Keywords
Ace2^em1(ACE2)Gpt	MGI:6452437	Endonuclease-mediated	Inserted expressed sequence						Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120	J:324335 J:340364	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ace2^em1(ACE2)Gpt Endonuclease-mediated			Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 SARS-CoV-2_virus\|VOC_B.1.351_Beta
Ace2^{em1(ACE2)Mlkn}	MGI:6842318	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Gao S, Front Cardiovasc Med 2023;10():1266276	J:315719 J:337814 J:346048	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus	Ace2^{em1(ACE2)Mlkn} Endonuclease-mediated			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Gao S, Front Cardiovasc Med 2023;10():1266276 Infection\|SARS-CoV-2_virus
Ace2^em1(ACE2)Rlu	MGI:7524682	Endonuclease-mediated	Humanized sequence\|Inserted expressed sequence						Romero MJ, Front Immunol 2023;14():1241448	J:339692	SARS-CoV-2_virus	Ace2^em1(ACE2)Rlu Endonuclease-mediated			Romero MJ, Front Immunol 2023;14():1241448 SARS-CoV-2_virus
Ace2^{em1(ACE2)Yowa}	MGI:6431336	Endonuclease-mediated	Humanized sequence\|Null/knockout\|Reporter	MGI:6431340	COVID-19	DOID:0080600	cardiovascular system homeostasis/metabolism immune system respiratory system	MP:0005385 MP:0005376 MP:0005387 MP:0005388	Sun SH, Cell Host Microbe 2020;20():1-10 Wu Y, Science 2020 Jun 12;368(6496):1274-1278 Yang J, Nature 2020 Jul 29;(): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Ye Q, bioRxiv 2020 Nov;(): Pinto D, bioRxiv 2020 Apr 9;(): Zhu L, bioRxiv 2020 Nov;(): Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 Chen J, bioRxiv 2021 Nov;():	J:288243 J:290802 J:292665 J:295349 J:295350 J:295351 J:296708 J:297123 J:298147 J:298750 J:315718	Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus	Ace2^{em1(ACE2)Yowa} Endonuclease-mediated	MGI:6431340	cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19	Sun SH, Cell Host Microbe 2020;20():1-10 Infection\|Pathology\|SARS-CoV-2_virus Wu Y, Science 2020 Jun 12;368(6496):1274-1278 SARS-CoV-2_virus\|Treatment Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Munoz-Fontela C, Nature 2020 Sep 23;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Ye Q, bioRxiv 2020 Nov;(): Pathology\|SARS-CoV-2_virus Pinto D, bioRxiv 2020 Apr 9;(): SARS-CoV-2_virus\|Treatment Zhu L, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine
Ace2^em1Cya	MGI:6500740	Endonuclease-mediated	Null/knockout	MGI:6500742			cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282	J:299383	Gene	Ace2^em1Cya Endonuclease-mediated	MGI:6500742	cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Gene
Ace2^em1Diam	MGI:7398548	Endonuclease-mediated	Null/knockout						Winkler ES, J Virol 2022 Jan 12;96(1):e0151121	J:331773	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Ace2^em1Diam Endonuclease-mediated			Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Ace2^em1Guru	MGI:6763023	Endonuclease-mediated	Humanized sequence						Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	Ace2^em1Guru Endonuclease-mediated			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
Ace2^em1Mccc	MGI:7468713	Endonuclease-mediated	Humanized sequence						Nakandakari-Higa S, Front Immunol 2022;13():1007080	J:335150	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^em1Mccc Endonuclease-mediated			Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em1Qhs	MGI:6415670	Endonuclease-mediated	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em1Qhs Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^em1Smoc	MGI:6415213	Endonuclease-mediated	Null/knockout						Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Li D, J Med Virol 2022 Oct;94(10):4878-4889	J:319435 J:339217	Gene\|Infection Infection\|SARS-CoV-2_virus	Ace2^em1Smoc Endonuclease-mediated			Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Gene\|Infection Li D, J Med Virol 2022 Oct;94(10):4878-4889 Infection\|SARS-CoV-2_virus
Ace2^{em2(ACE2/GFP)Mlkn}	MGI:6842319	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout\|Reporter						Tang AT, bioRxiv 2021 Dec;():	J:315719	Pathology\|SARS-CoV-2_virus	Ace2^{em2(ACE2/GFP)Mlkn} Endonuclease-mediated			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus
Ace2^em2(ACE2)Gpt	MGI:6452442	Endonuclease-mediated	Inserted expressed sequence	MGI:6514876			growth/size/body immune system respiratory system	MP:0005378 MP:0005387 MP:0005388	Wu X, bioRxiv 2021 Feb;():	J:302150	SARS-CoV-2_virus\|Treatment	Ace2^em2(ACE2)Gpt Endonuclease-mediated	MGI:6514876	growth/size/body immune system respiratory system	Wu X, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment
Ace2^{em2(ACE2)Mlkn}	MGI:7507528	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout						Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^{em2(ACE2)Mlkn} Endonuclease-mediated			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em2Guru	MGI:6763025	Endonuclease-mediated	Humanized sequence						Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	Ace2^em2Guru Endonuclease-mediated			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
Ace2^em2Mccc	MGI:7468714	Endonuclease-mediated	Humanized sequence						Nakandakari-Higa S, Front Immunol 2022;13():1007080	J:335150	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^em2Mccc Endonuclease-mediated			Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em2Shyy	MGI:6406965	Endonuclease-mediated	Not Specified						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em2Shyy Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^em#Yngh	MGI:5752578	Endonuclease-mediated	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em#Yngh Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^{tm1(ACE2)Dwnt}	MGI:6469881	Targeted	Humanized sequence\|Inserted expressed sequence						Zhou B, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Ulrich L, bioRxiv 2021 Jun;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Perico L, Sci Rep 2023 Jul 14;13(1):11392 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120	J:296356 J:305777 J:308620 J:331773 J:338324 J:338414	Infection\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron	Ace2^{tm1(ACE2)Dwnt} Targeted			Zhou B, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus Ulrich L, bioRxiv 2021 Jun;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Perico L, Sci Rep 2023 Jul 14;13(1):11392 Pathology\|SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron
Ace2^{tm1a(KOMP)Wtsi}	MGI:4820112	Targeted	Conditional ready\|Null/knockout\|Reporter						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^{tm1a(KOMP)Wtsi} Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^{tm1c(KOMP)Wtsi}	MGI:6415205	Targeted	Conditional ready						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^{tm1c(KOMP)Wtsi} Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^tm1Cof	MGI:3665270	Targeted	Null/knockout						Ji H, Hypertension 2020 Aug;76(2):478-487 Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:290256 J:296535	Gene SARS-CoV-2_virus	Ace2^tm1Cof Targeted			Ji H, Hypertension 2020 Aug;76(2):478-487 Gene Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^tm1Hira	MGI:3794966	Targeted	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165 Wang Y, FASEB J 2021 Mar;35(3):e21419	J:296535 J:309535	SARS-CoV-2_virus Gene	Ace2^tm1Hira Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Wang Y, FASEB J 2021 Mar;35(3):e21419 Gene
Ace2^tm1Lex	MGI:5007005	Targeted	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165 Bilinska K, bioRxiv 2021 Apr;():	J:296535 J:304622	SARS-CoV-2_virus Gene	Ace2^tm1Lex Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Bilinska K, bioRxiv 2021 Apr;(): Gene
Ace2^tm1Pngr	MGI:2661723	Targeted	Null/knockout	MGI:5912243 MGI:6402915			cardiovascular system immune system	MP:0005385 MP:0005387	Kuba K, Nat Med 2005 Aug;11(8):875-9 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Gawish R, Elife 2022 Jan 13;11():e74623	J:286299 J:294026 J:296535 J:318828	Infection\|SARS-CoV_virus SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus Pathology\|SARS-CoV-2-MA_virus	Ace2^tm1Pngr Targeted	MGI:5912243 MGI:6402915	cardiovascular system immune system	Kuba K, Nat Med 2005 Aug;11(8):875-9 Infection\|SARS-CoV_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus
Ace^tm4Keb	MGI:2665017	Targeted	Null/knockout						Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943	J:294060	SARS-CoV-2_virus	Ace^tm4Keb Targeted			Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus
Ace^tm7Keb	MGI:3783350	Targeted	Modified isoform(s)						Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943	J:294060	SARS-CoV-2_virus	Ace^tm7Keb Targeted			Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus
Adar^tm1.1Phs	MGI:3828307	Targeted	Conditional ready\|No functional change						Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038	J:333092	Gene\|VOC_B.1.351_Beta	Adar^tm1.1Phs Targeted			Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Gene\|VOC_B.1.351_Beta
Adh5^{Gt(IST12290F1)Tigm}	MGI:4065198	Gene trapped	Null/knockout\|Reporter						Kim J, Front Pharmacol 2023;14():1304697	J:343781	SARS-CoV-2_virus\|Treatment	Adh5^{Gt(IST12290F1)Tigm} Gene trapped			Kim J, Front Pharmacol 2023;14():1304697 SARS-CoV-2_virus\|Treatment
Aicda^{tm1.1(cre/ERT2)Crey}	MGI:4437052	Targeted	Inducible\|Null/knockout\|Recombinase						Gregoire C, bioRxiv 2021 Dec;():	J:316768	SARS-CoV-2_virus	Aicda^{tm1.1(cre/ERT2)Crey} Targeted			Gregoire C, bioRxiv 2021 Dec;(): SARS-CoV-2_virus
Aicda^tm1Hon	MGI:2156156	Targeted	Null/knockout						Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	Aicda^tm1Hon Targeted			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
Aim2^tm1.1Vmd	MGI:5428935	Targeted	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Aim2^tm1.1Vmd Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Apaf1^tm1Her	MGI:1860245	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Apaf1^tm1Her Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Apoe^{tm1(APOE*2)Mae}	MGI:2158396	Targeted	Humanized sequence\|Inserted expressed sequence						Ostendorf BN, Nature 2022 Nov;611(7935):346-351	J:340480	Gene\|SARS-CoV-2-MA_virus	Apoe^{tm1(APOE*2)Mae} Targeted			Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Gene\|SARS-CoV-2-MA_virus
Apoe^{tm2(APOE*3)Mae}	MGI:2157240	Targeted	Humanized sequence\|Inserted expressed sequence\|Modified isoform(s)\|Null/knockout						Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378	J:305558	SARS-CoV-2_virus	Apoe^{tm2(APOE*3)Mae} Targeted			Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 SARS-CoV-2_virus
Apoe^{tm3(APOE*4)Mae}	MGI:2158398	Targeted	Humanized sequence\|Inserted expressed sequence						Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 Ostendorf BN, Nature 2022 Nov;611(7935):346-351	J:305558 J:340480	SARS-CoV-2_virus Gene\|SARS-CoV-2-MA_virus	Apoe^{tm3(APOE*4)Mae} Targeted			Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 SARS-CoV-2_virus Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Gene\|SARS-CoV-2-MA_virus
App^tm3.1Tcs	MGI:5637817	Targeted	Humanized sequence						Magusali N, bioRxiv 2021 Mar;():	J:303205	Comorbidity	App^tm3.1Tcs Targeted			Magusali N, bioRxiv 2021 Mar;(): Comorbidity
Atg5^tm1Myok	MGI:3663625	Targeted	Conditional ready\|No functional change						Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5	J:282479	Mouse_Hepatitis_virus	Atg5^tm1Myok Targeted			Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Mouse_Hepatitis_virus
B2m^tm1Unc	MGI:1857133	Targeted	Null/knockout						Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83	J:308658 J:33974 J:54035	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	B2m^tm1Unc Targeted			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83 Mouse_Hepatitis_virus\|Pathology
Batf3^tm1Kmm	MGI:3817232	Targeted	Null/knockout						Ndeupen S, bioRxiv 2021 Aug;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308580 J:345954	SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus	Batf3^tm1Kmm Targeted			Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Bcl6^tm1.1Dent	MGI:5518542	Targeted	Conditional ready\|No functional change						Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	Bcl6^tm1.1Dent Targeted			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
Bsg^tm1(BSG)Smoc	MGI:6430241	Targeted	Humanized sequence\|Inserted expressed sequence						Geng J, bioRxiv 2021 May;():	J:308748	SARS-CoV-2_virus	Bsg^tm1(BSG)Smoc Targeted			Geng J, bioRxiv 2021 May;(): SARS-CoV-2_virus
C1qa^{tm1d(EUCOMM)Wtsi}	MGI:6151469	Targeted	Null/knockout						Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	C1qa^{tm1d(EUCOMM)Wtsi} Targeted			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
C3^tm1Crr	MGI:1861799	Targeted	Null/knockout	MGI:3799624			homeostasis/metabolism immune system nervous system vision/eye	MP:0005376 MP:0005387 MP:0003631 MP:0005391	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	C3^tm1Crr Targeted	MGI:3799624	homeostasis/metabolism immune system nervous system vision/eye	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
C4b^tm1Crr	MGI:1889070	Targeted	Null/knockout	MGI:5296003			homeostasis/metabolism immune system renal/urinary system	MP:0005376 MP:0005387 MP:0005367	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	C4b^tm1Crr Targeted	MGI:5296003	homeostasis/metabolism immune system renal/urinary system	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
C5ar1^{tm1.1(C5AR1)Cmac}	MGI:6449073	Targeted	Humanized sequence\|Inserted expressed sequence\|Null/knockout						Carvelli J, Nature 2020 Jul 29;():	J:291890	Pathology\|SARS-CoV-2_virus\|Treatment	C5ar1^{tm1.1(C5AR1)Cmac} Targeted			Carvelli J, Nature 2020 Jul 29;(): Pathology\|SARS-CoV-2_virus\|Treatment
Casp1^tm1Flv	MGI:2158744	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;(): Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:292665 J:298138 J:323769 J:331762 J:331829	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus Gene\|Pathology	Casp1^tm1Flv Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Casp1^tm1Gne	MGI:5882087	Targeted	Null/knockout						Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118	J:313327	SARS-CoV-2_virus\|Vaccine	Casp1^tm1Gne Targeted			Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine
Casp1^tm1Sesh	MGI:1927822	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp1^tm1Sesh Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp3^tm1Flv	MGI:2158753	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp3^tm1Flv Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp4^del	MGI:5473345	Spontaneous	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Casp4^del Spontaneous			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Casp4^tm1.1Vmd	MGI:5468949	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp4^tm1.1Vmd Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp4^tm1Yuan	MGI:2159366	Targeted	Null/knockout						Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119	J:311911 J:331823	Gene\|SARS-CoV-2-MA_virus Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Casp4^tm1Yuan Targeted			Eltobgy M, bioRxiv 2021;(): Gene\|SARS-CoV-2-MA_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Casp7^tm1Flv	MGI:3603317	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp7^tm1Flv Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp8^tm1.1Raz	MGI:5546196	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	Casp8^tm1.1Raz Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Ccl2^tm1Rol	MGI:2175911	Targeted	Null/knockout						Held KS, Virology 2004 Nov 24;329(2):251-60	J:102446	Infection\|Mouse_Hepatitis_virus	Ccl2^tm1Rol Targeted			Held KS, Virology 2004 Nov 24;329(2):251-60 Infection\|Mouse_Hepatitis_virus
Ccr1^tm1Gao	MGI:1931850	Targeted	Null/knockout	MGI:3614443	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	Ccr1^tm1Gao Targeted	MGI:3614443	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr2^tm1Ifc	MGI:2158213	Targeted	Null/knockout	MGI:3580323			cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0002006 MP:0010768	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92	J:106738	Mouse_Hepatitis_virus\|Pathology	Ccr2^tm1Ifc Targeted	MGI:3580323	cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus\|Pathology
Ccr2^tm1Mae	MGI:2158345	Targeted	Null/knockout	MGI:3841005	age related macular degeneration Coronavirus infectious disease	DOID:10871 DOID:0080599	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye	MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391	Held KS, Virology 2004 Nov 24;329(2):251-60 Glass WG, Virology 2001 Sep 15;288(1):8-17 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:102446 J:102561 J:162707	Infection\|Mouse_Hepatitis_virus Mouse_Hepatitis_virus Pathology\|SARS-CoV-MA_virus	Ccr2^tm1Mae Targeted	MGI:3841005	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease	Held KS, Virology 2004 Nov 24;329(2):251-60 Infection\|Mouse_Hepatitis_virus Glass WG, Virology 2001 Sep 15;288(1):8-17 Mouse_Hepatitis_virus Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr5^tm1Kuz	MGI:1861911	Targeted	Null/knockout	MGI:4418655	Coronavirus infectious disease	DOID:0080599	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	Ccr5^tm1Kuz Targeted	MGI:4418655	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr9^tm1Lov	MGI:3654108	Targeted	Null/knockout						Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:308730 J:327836	Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	Ccr9^tm1Lov Targeted			Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
Cd19^tm1(cre)Cgn	MGI:1931143	Targeted	Recombinase						Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Atkinson JR, J Virol 2017 Dec 1;91(23): Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:143484 J:253411 J:322643 J:333746 J:336666	Mouse_Hepatitis_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine Comorbidity\|SARS-CoV-2_virus	Cd19^tm1(cre)Cgn Targeted			Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Atkinson JR, J Virol 2017 Dec 1;91(23): Mouse_Hepatitis_virus Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity\|SARS-CoV-2_virus
Cd1^tm1Gru	MGI:1857482	Targeted	Null/knockout						Johansen MD, Mucosal Immunol 2020 Aug 20;(): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:295350 J:92752	MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Infection\|SARS-CoV_virus	Cd1^tm1Gru Targeted			Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
Cd274^tm1Lpc	MGI:3043876	Targeted	Null/knockout						Phares TW, J Immunol 2009 May 1;182(9):5430-8 Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Phares TW, J Neuroinflammation 2012 Dec 14;9():269	J:147948 J:165192 J:331800	Mouse_Hepatitis_virus Gene\|Mouse_Hepatitis_virus	Cd274^tm1Lpc Targeted			Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Mouse_Hepatitis_virus Phares TW, J Neuroinflammation 2012 Dec 14;9():269 Gene\|Mouse_Hepatitis_virus
Cd47^tm1Fpl	MGI:1861955	Targeted	Null/knockout						Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	Cd47^tm1Fpl Targeted			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
Cd4^tm1Knw	MGI:1857143	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Cd4^tm1Knw Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Cd4^tm1Litt	MGI:1857281	Targeted	Null/knockout						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Cd4^tm1Litt Targeted			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Cd4^tm1Mak	MGI:1857144	Targeted	Null/knockout						Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Chakravarty D, J Virol 2020 Jul 1;94(14):	J:112983 J:290222	Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	Cd4^tm1Mak Targeted			Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Mouse_Hepatitis_virus Chakravarty D, J Virol 2020 Jul 1;94(14): Mouse_Hepatitis_virus\|Pathology
Cd79a^tm1(cre)Reth	MGI:3687451	Targeted	Null/knockout\|Recombinase						Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	Cd79a^tm1(cre)Reth Targeted			Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
Cd8a^tm1Mak	MGI:1857149	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Cd8a^tm1Mak Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Ceacam1^Hv2-r	MGI:3053078	Spontaneous		MGI:3719417			immune system	MP:0005387	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8	J:240703 J:3241 J:701 J:92495	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^Hv2-r Spontaneous	MGI:3719417	immune system	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus
Ceacam1^Hv2-s	MGI:3027072	Spontaneous		MGI:3719418			immune system	MP:0005387	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8	J:240703 J:3241 J:701 J:92495	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^Hv2-s Spontaneous	MGI:3719418	immune system	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm1.1Fta	MGI:5496530	Targeted	Inserted expressed sequence	MGI:5496535			immune system mortality/aging	MP:0005387 MP:0010768	Hirai A, J Virol 2010 Jul;84(13):6654-66	J:198335	Infection\|Mouse_Hepatitis_virus	Ceacam1^tm1.1Fta Targeted	MGI:5496535	immune system mortality/aging	Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm1Bcn	MGI:2180785	Targeted	Null/knockout	MGI:2656211			immune system mortality/aging	MP:0005387 MP:0010768	Blau DM, J Virol 2001 Sep;75(17):8173-86 Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:70815 J:92376	Infection\|Mouse_Hepatitis_virus	Ceacam1^tm1Bcn Targeted	MGI:2656211	immune system mortality/aging	Blau DM, J Virol 2001 Sep;75(17):8173-86 Infection\|Mouse_Hepatitis_virus Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm2Bcn	MGI:3053071	Targeted	Null/knockout	MGI:3053437			digestive/alimentary system homeostasis/metabolism immune system neoplasm	MP:0005381 MP:0005376 MP:0005387 MP:0002006	Miura TA, J Virol 2008 Jan;82(2):755-63 Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:130131 J:92376	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^tm2Bcn Targeted	MGI:3053437	digestive/alimentary system homeostasis/metabolism immune system neoplasm	Miura TA, J Virol 2008 Jan;82(2):755-63 Mouse_Hepatitis_virus Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
Ces1c^tm1.1Loc	MGI:4938302	Targeted	Null/knockout						Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Martinez DR, bioRxiv 2021 Jan;(): Zhu C, Nat Commun 2022 Aug 3;13(1):4503	J:286362 J:286402 J:298752 J:302135 J:335969	MERS-CoV_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Treatment SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment	Ces1c^tm1.1Loc Targeted			Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): MERS-CoV_virus\|SARS-CoV_virus\|Treatment Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus\|Treatment Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Martinez DR, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment
Cfb^tm1Hrc	MGI:1861129	Targeted	Null/knockout	MGI:3771614			immune system	MP:0005387	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	Cfb^tm1Hrc Targeted	MGI:3771614	immune system	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
Ch25h^tm1Rus	MGI:4947407	Targeted	Null/knockout						Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	Ch25h^tm1Rus Targeted			Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
Ciita^tm1Ccum	MGI:1857456	Targeted	Null/knockout						Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ciita^tm1Ccum Targeted			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
Cmpk2^{tm1c(KOMP)Wtsi}	MGI:6753388	Targeted	Conditional ready						Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11	J:308159	Pathology\|SARS-CoV-2_virus\|Treatment	Cmpk2^{tm1c(KOMP)Wtsi} Targeted			Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Pathology\|SARS-CoV-2_virus\|Treatment
Col1a1^{tm1(tetO-Cpt1a,-GFP)Slms}	MGI:7564295	Targeted	Inducible\|Inserted expressed sequence						Miguel V, Redox Biol 2023 Dec;68():102957	J:343262	Treatment	Col1a1^{tm1(tetO-Cpt1a,-GFP)Slms} Targeted			Miguel V, Redox Biol 2023 Dec;68():102957 Treatment
Commd10^{Tg(Vav1-icre)A2Kio}	MGI:2449949	Transgenic	Null/knockout\|Recombinase						Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Commd10^{Tg(Vav1-icre)A2Kio} Transgenic			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Csf1^{tm1.1(CSF1)Flv}	MGI:5296679	Targeted	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Csf1^{tm1.1(CSF1)Flv} Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Csf2/Il3^{tm1.1(CSF2,IL3)Flv}	MGI:4887881	Targeted	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Csf2^tm1Mlg	MGI:1930996	Targeted	Null/knockout						Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	Csf2^tm1Mlg Targeted			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Ctnnb1^tm1Knw	MGI:3767601	Targeted	Conditional ready						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Ctnnb1^tm1Knw Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Cx3cr1^tm1Litt	MGI:2670351	Targeted	Null/knockout\|Reporter						Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943	J:291614	Mouse_Hepatitis_virus	Cx3cr1^tm1Litt Targeted			Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Mouse_Hepatitis_virus
Cx3cr1^{tm2.1(cre/ERT2)Litt}	MGI:5450813	Targeted	Inducible\|Recombinase\|Reporter						Verma AK, mBio 2021 Oct 26;12(5):e0196921	J:313438	Mouse_Hepatitis_virus	Cx3cr1^{tm2.1(cre/ERT2)Litt} Targeted			Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus
Cxcl10^tm1Adl	MGI:2180678	Targeted	Null/knockout						Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80	J:140673	Mouse_Hepatitis_virus	Cxcl10^tm1Adl Targeted			Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80 Mouse_Hepatitis_virus
Cxcl13^tm1Cys	MGI:2384500	Targeted	Null/knockout\|Reporter						Phares TW, Brain Behav Immun 2016 May;54():128-139	J:316468	Mouse_Hepatitis_virus	Cxcl13^tm1Cys Targeted			Phares TW, Brain Behav Immun 2016 May;54():128-139 Mouse_Hepatitis_virus
Cxcl5^tm1Gscw	MGI:4819800	Targeted	Null/knockout						Liang Y, Zool Res 2020 Oct 12;():1-29	J:296738	Infection\|Pathology\|SARS-CoV-2_virus	Cxcl5^tm1Gscw Targeted			Liang Y, Zool Res 2020 Oct 12;():1-29 Infection\|Pathology\|SARS-CoV-2_virus
Cxcr3^tm1Dgen	MGI:3604545	Targeted	Null/knockout\|Reporter						McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Cxcr3^tm1Dgen Targeted			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Cxcr6^tm1Litt	MGI:3613526	Targeted	Null/knockout\|Reporter						Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:327836	SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	Cxcr6^tm1Litt Targeted			Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
Dpp4^em1Rba	MGI:6400423	Endonuclease-mediated	Humanized sequence	MGI:6400425	Middle East respiratory syndrome	DOID:0080642	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Leist SR, PLoS One 2019;14(7):e0220126 Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, Methods Mol Biol 2020;2099():137-159 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Menachery VD, mBio 2017 Aug 22;8(4): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3):	J:279723 J:279834 J:285962 J:286320 J:286402 J:287147 J:295349 J:295350 J:300138	MERS-CoV_virus\|Pathology MERS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Treatment Infection\|MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus	Dpp4^em1Rba Endonuclease-mediated	MGI:6400425	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Leist SR, PLoS One 2019;14(7):e0220126 MERS-CoV_virus\|Pathology Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 MERS-CoV_virus Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus\|Treatment Menachery VD, mBio 2017 Aug 22;8(4): Infection\|MERS-CoV_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): MERS-CoV_virus
Dpp4^{em2(DPP4)Smoc}	MGI:6415291	Endonuclease-mediated	Inserted expressed sequence						Xia LY, Nat Commun 2024 Feb 5;15(1):1048	J:353426	Infection	Dpp4^{em2(DPP4)Smoc} Endonuclease-mediated			Xia LY, Nat Commun 2024 Feb 5;15(1):1048 Infection
Dpp4^{tm1.1(DPP4)Pbmj}	MGI:6400999	Targeted	Humanized sequence\|Inserted expressed sequence	MGI:6401000	Middle East respiratory syndrome	DOID:0080642	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Leist SR, Methods Mol Biol 2020;2099():137-159 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Li K, mBio 2020 Apr 7;11(2): Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): Zheng J, J Clin Invest 2021 Jun 1;131(11): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 Wong L-YR, mBio 2023 Oct 26;14(6):e0247623	J:242025 J:285962 J:286329 J:287921 J:288107 J:295349 J:295350 J:300104 J:300138 J:311966 J:315826 J:343780	Infection\|MERS-CoV-MA_virus\|Pathology MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Infection\|MERS-CoV-MA_virus\|Treatment MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Comorbidity\|MERS-CoV_virus MERS-CoV_virus\|Vaccine MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus	Dpp4^{tm1.1(DPP4)Pbmj} Targeted	MGI:6401000	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Infection\|MERS-CoV-MA_virus\|Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Jia W, Emerg Microbes Infect 2019;8(1):760-772 MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Li K, mBio 2020 Apr 7;11(2): MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): MERS-CoV_virus Zheng J, J Clin Invest 2021 Jun 1;131(11): Comorbidity\|MERS-CoV_virus Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 MERS-CoV_virus\|Vaccine Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus
Dpp4^{tm1(DPP4)Vlcg}	MGI:5788094	Targeted	Inserted expressed sequence\|Null/knockout	MGI:6400455 MGI:6435210	Middle East respiratory syndrome	DOID:0080642	immune system respiratory system hematopoietic system homeostasis/metabolism	MP:0005387 MP:0005388 MP:0005397 MP:0005376	Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Coleman CM, J Virol 2017 Jan 01;91(1): Leist SR, Methods Mol Biol 2020;2099():137-159 Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Singh A, Virol Sin 2020 Jun;35(3):290-304	J:223728 J:238079 J:285962 J:286238 J:295349	Infection\|MERS-CoV_virus\|Treatment MERS-CoV_virus\|Pathology MERS-CoV_virus Comorbidity\|MERS-CoV_virus\|Pathology MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Dpp4^{tm1(DPP4)Vlcg} Targeted	MGI:6400455 MGI:6435210	immune system respiratory system Middle East respiratory syndrome hematopoietic system homeostasis/metabolism	Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Infection\|MERS-CoV_virus\|Treatment Coleman CM, J Virol 2017 Jan 01;91(1): MERS-CoV_virus\|Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Comorbidity\|MERS-CoV_virus\|Pathology Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Dyrk1a^tm1Jdc	MGI:5648391	Targeted	Conditional ready\|No functional change						Strine MS, PLoS Biol 2023 Jun;21(6):e3002097	J:341033	Gene\|MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Dyrk1a^tm1Jdc Targeted			Strine MS, PLoS Biol 2023 Jun;21(6):e3002097 Gene\|MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Ebi3^Gt716Lex	MGI:3793965	Gene trapped	Null/knockout\|Reporter	MGI:6442003			hematopoietic system immune system nervous system mortality/aging	MP:0005397 MP:0005387 MP:0003631 MP:0010768	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6	J:286951	Infection\|Mouse_Hepatitis_virus	Ebi3^Gt716Lex Gene trapped	MGI:6442003	hematopoietic system immune system nervous system mortality/aging	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6 Infection\|Mouse_Hepatitis_virus
Edil3^{Tg(Sox2-cre)1Amc}	MGI:2656539	Transgenic	Null/knockout\|Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Edil3^{Tg(Sox2-cre)1Amc} Transgenic			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Egfr^Mhdadsk5	MGI:2682255	Chemically induced (ENU)							Venkataraman T, J Virol 2017 Jun 15;91(12):	J:243599	Pathology\|SARS-CoV-MA_virus	Egfr^Mhdadsk5 Chemically induced (ENU)			Venkataraman T, J Virol 2017 Jun 15;91(12): Pathology\|SARS-CoV-MA_virus
Eif2ak2^tm1Cwe	MGI:2182566	Targeted	Null/knockout						Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:291588	HCoV-229E_virus\|Mouse_Hepatitis_virus	Eif2ak2^tm1Cwe Targeted			Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus\|Mouse_Hepatitis_virus
Elane^tm1Sds	MGI:2182771	Targeted	Null/knockout						Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118	J:313327	SARS-CoV-2_virus\|Vaccine	Elane^tm1Sds Targeted			Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine
Epor^{tm1.1(EGFP/icre)Uk}	MGI:3052727	Targeted	Null/knockout\|Recombinase\|Reporter						Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008	J:325468	SARS-CoV-2_virus	Epor^{tm1.1(EGFP/icre)Uk} Targeted			Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 SARS-CoV-2_virus
Fadd^tm1Mak	MGI:2159360	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Fadd^tm1Mak Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Fadd^tm1Mpa	MGI:3700154	Targeted	Conditional ready\|No functional change						Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:323957	Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta	Fadd^tm1Mpa Targeted			Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta
Fcer1g^tm1Rav	MGI:1857165	Targeted	Null/knockout						Adams LE, Cell Rep 2023 Mar 30;42(4):112326	J:349062	SARS-CoV-2-MA_virus\|Vaccine	Fcer1g^tm1Rav Targeted			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine
Fcgrt^tm1Dcr	MGI:3511510	Targeted	Null/knockout						Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Fcgrt^tm1Dcr Targeted			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Fga^tm1Jld	MGI:2152976	Targeted	Null/knockout						Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus\|Treatment	Fga^tm1Jld Targeted			Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment
Fgg^tm2Jld	MGI:3046446	Targeted							Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus\|Treatment	Fgg^tm2Jld Targeted			Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment
Fgl2^tm1Pam	MGI:3582343	Targeted	Null/knockout\|Reporter	MGI:3583696 MGI:3583697	autoimmune glomerulonephritis	DOID:0040094	cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system	MP:0005385 MP:0005376 MP:0005387 MP:0010768 MP:0005384 MP:0005378 MP:0005397 MP:0005367	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66	J:99453	Mouse_Hepatitis_virus	Fgl2^tm1Pam Targeted	MGI:3583696 MGI:3583697	cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system autoimmune glomerulonephritis	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 Mouse_Hepatitis_virus
Foxg1^{tm1.1(cre)Ddmo}	MGI:5818697	Targeted	Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Foxg1^{tm1.1(cre)Ddmo} Targeted			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Foxp3^tm2Ayr	MGI:3574964	Targeted	No functional change\|Reporter						Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7	J:177608	Mouse_Hepatitis_virus	Foxp3^tm2Ayr Targeted			Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 Mouse_Hepatitis_virus
Foxp3^tm2Tch	MGI:3699400	Targeted	Reporter						Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997	J:247329 J:324704	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Foxp3^tm2Tch Targeted			Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Mouse_Hepatitis_virus Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection\|Mouse_Hepatitis_virus
Foxp3^{tm3(HBEGF/GFP)Ayr}	MGI:3698131	Targeted	Inserted expressed sequence\|Reporter						Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085	J:327784	SARS-CoV-2_virus	Foxp3^{tm3(HBEGF/GFP)Ayr} Targeted			Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 SARS-CoV-2_virus
Foxp3^{tm4(YFP/icre)Ayr}	MGI:3790499	Targeted	Recombinase						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Foxp3^{tm4(YFP/icre)Ayr} Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Foxp3^{tm9(EGFP/cre/ERT2)Ayr}	MGI:4950935	Targeted	Inducible\|Recombinase\|Reporter						Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997	J:324704	Infection\|Mouse_Hepatitis_virus	Foxp3^{tm9(EGFP/cre/ERT2)Ayr} Targeted			Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection\|Mouse_Hepatitis_virus
G3bp1^em1Gpt	MGI:7299354	Endonuclease-mediated	Conditional ready\|No functional change						Liu H, J Virol 2022 Jun 22;96(12):e0041222	J:342298	Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	G3bp1^em1Gpt Endonuclease-mediated

Mouse Models for Coronavirus Research

The Global COVID-19 Pandemic

About this Site: Coronavirus Research using the Laboratory Mouse

Mouse Strains Used in Coronavirus Research